| Legend | WG Sessions / Scientific Content | Abstract Sessions | Plenary & Keynote Lectures | Working Group Meetings |
26
| 08:00 – 15:40 | UPDATE COURSE |
| 16:00 – 17:30 |
OPENING CEREMONY & MANNHEIMER LECTURE Pediatric Cardiology across the life span. Building the future of congenital heart care 2026-2046, Ornella Milanesi, Italy |
| 17:30 – 19:00 |
WELCOME RECEPTION Location : Exhibition & Posters’ Area and Foyers |
| 08:00 – 15:40 | NURSING & AHP EDUCATION DAY |
| 12:30 – 13:30 |
Young Community Meeting: Updates, Opportunities and Future Directions 12:30 – 12:40 Young Community Updates: Current Activities and Future Plans Sara Moscatelli, UK 12:40 – 12:50 Navigating Research Grants and International Exchanges: Keys to Success Werner Budts, Belgium 12:50 – 13:00 Succeeding in the Japan Exchange Programme: Practical Tips, Tricks and Personal Insights Domenico Sirico, Italy 13:00 – 13:10 How to Secure AEPC Research Grants: Tips, Tricks and Lessons Learned Alessia Callegari, Italy |
| 17:30 – 19:00 |
WELCOME RECEPTION Location : Exhibition & Posters’ Area and Foyers |
| 08:00 – 09:00 |
Fetal Cardiology WG Business Meeting |
| 09:00 – 11:00 |
AEPC Update Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Artificial Intelligence in Perinatal Cardiology |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Joint Session Canadian Pediatric Cardiology Association (CPCA) – AEPC Chairs: Biagio Castaldi, Italy & Marisha McClean, Canada 14:30 – 14:52 Choosing the Right Imaging Modality, Francesca Raimondi, Italy 14:52 – 15:14 Artificial Intelligence and Virtual Reality: Will Technology Help Us Use Less Radiation, Robert Chen, Canada 15:14 – 15:36 Cumulative Radiation Exposure in Congenital Heart Disease: Are We Accounting for Lifetime Risk?, Michael Hofbeck, Germany 15:36 – 15:58 Fluoroscopy-Free and Low-Dose Interventions: Current Practice and Future Directions, Nicholas Fitzgerald, Canada |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Advanced Imaging, 3D Reconstructions and Virtual Reality: How It Applies to Cardiac Morphology Chairs: Annalisa Angelini, Italy & Gabriele Rinelli, Italy
16:30 – 16:52 Navigating in Heart Specimens: Augmented Reality,
Cloé Huet, France & Segolene Bernheim, France |
| 08:00 – 09:00 | Cardiac Dysrhythmias & Electrophysiology WG Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Coronary Arteries Anomalies and Sport Chairs: Ugo Giordano, Italy & Francesca Raimondi, Italy
11:30 – 11:52 Playing Sport with Coronary Anomalies: When is Safe and When is Not,
Joao Rato, Portugal |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Current State of the Art in CMR: What’s New for You? Chairs: Tarek Alsaied, USA & Heynric Grotenhuis, The Netherlands
14:30 – 14:52 Stress CMR and its Application in P/CHD,
Tam Doan, USA |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Cardiac Imaging Abstract Session Chair: Almudena Ortiz, USA & Sylvia Krupickova, UK
16:30 – 16:37 O-026 Tricuspid Septal Offsetting in Healthy Children: Age-Specific Reference Values to Refine Ebstein Anomaly Diagnosis,
Simon Alexander Classen, Denmark |
| 08:00 – 09:00 | Interventional Cardiology WG Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Interventions in Premature Babies Chairs: Petra Louriero, Portugal & Petru Liuba, Sweden
11:30 – 11:52 The Critically Ill Premature Baby – What is Possible in the Cath Lab?,
Stanimir Georgiev, Germany |
| LUNCH BREAK | |
| 14:30 – 16:00 |
The Large Right Ventricular Outflow Tract – Valves and Other Options
Joint WG: Interventional Cardiology & Cardiac Imaging & Congenital Heart Surgery
Chairs: Shakeel Qureshi, UK & Vladimiro Vida, Italy
14:30 – 14:52 Anatomical Challenges in Large RVOT: Defining the Candidates and the Landscape, Peter Ewert, Germany
14:52 – 15:14 TPVR Strategies for Large RVOTs: What’s Available and When to Choose Self-Expanding, Shakeel Qureshi, UK
15:14 – 15:36 Balloon-Expandable Valves in Large RVOT: When and Why They Still Matter, Enrico Piccinelli, Italy
15:36 – 15:58 When Not to Intervene Percutaneously: Hybrid and Surgical Insights Into Challenging RVOTs, Joachim Photiadis, Germany
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 | Challenges in Becoming an Interventional Cardiologist
Joint WG: Interventional Cardiology & Education Committee
Chairs: Michael Rigby, UK & Ina Michel Behnke, Austria 16:30 – 16:48 Expectations – the Trainers View, Gianfranco Butera, Italy
16:48 – 17:06 Expectations – The Trainees View, Alessia Callegari, Italy
17:06 – 17:24 Training Guidelines, Thomas Krasemann, The Netherlands
17:24 – 17:42 How Does This Fit into the General Training?, Ruth Heying, Belgium
17:42 – 18:00 Isn’t this too much?, Sigitas Cesna, Lithuania |
| 08:00 – 09:00 | Clinical trials TF Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Fake Hearts, Real Insight – Videodemonstration of Heart Specimens and 3D Models Chairs: Cristina Basso, Italy & Matthias Sigler, Germany
11:30 – 11:52 Ventricular Septal Defects,
Gaetano Thiene |
| 13:00 – 14:30 |
Juniors Meet Seniors Chairs: Enrico Piccinelli, Italy & Thomas Krasemann, The Netherlands
|
| 14:30 – 16:00 |
Speckle Tracking Echocardiography in CHD: Where Are We? Chairs: Colin McMahon, Ireland & Pei-Ni Jone, USA
14:30 – 14:52 Ventricular strain in children with CHD: reliable and reproducible?,
Giovanni Di Salvo, Italy |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
How to Make an Electrocardiographic Diagnosis of Selected Pathologies Chairs: Fabrizio Drago, Italy & Jan Janousek, Czechia
16:30 – 16:48 Long QT Syndrome,
Tomasz Książczyk, Poland |
| 08:00 – 09:00 | Pulmonary hypertension, heart failure and transplantation WG Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Pharmacotherapy in Pediatric Heart Failure Chairs: Michael Burch, UK & Hakan Wahlander, Sweden
11:30 – 11:52 Pediatric Drug Trials in Heart Failure – Update,
Michael Burch, UK |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Right Heart Failure Management in the Intensive Care Unit Chairs: Menno Douwes, The Netherlands& Roxana Emache, Romania
14:30 – 14:52 Treatment of Acute Right Heart Failure in the ICU,
Cho Ng, UK |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Failing Single Ventricles in Adult CHD Patients – Challenges and Potential Solutions Chairs: Yi Wang, China& Werner Budts, Belgium
16:30 – 16:52 Failing Single Ventricles in ACHD – Optimising Medical Management,
Giancarlo Scognamiglio, Italy |
| 08:00 – 09:00 | Adult congenital heart disease WG Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
AI and ChatGPT: Advanced Imaging, Artificial Intelligence and Virtual Reality Chairs: Eva Goossens, Belgium & Edward Callus, Italy
11:30 – 11:52 Enhanced Diagnostics & Treatments – Applications of AI in CHD Care,
Jef Van den Eynde, Belgium |
13:00 – 14:30 |
Lunch Break
|
| 14:30 – 16:00 |
Exercise in Children with Cardiomyopathies: A Case-based Session Chairs: Joao Rato, Portugal & Andrea Greco, Spain
14:30 – 14:52 How Do I Handle Physical Activity in an Athlete with Newly Diagnosed ARVC?,
Domenico Corrado, Italy |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Hearts Under Pressure – Doping, Supplements and the Cardiovascular Costs of Enhancements Chairs: Antonello D’Andrea, Italy & Renata Oberhoffer, Germany
16:30 – 16:52 The Systemic Effects of Steroids, Growth Enhancer Substances, EPO,
Armando Grossi, Italy |
| 08:00 – 09:00 | Neurodevelopment and Psychosocial Care WG Business Meeting |
| 11:00 – 11:30 | BREAK |
| 11:30 – 13:00 |
Flash Talk Session 1
Chair: Anwar Baban, UEA & Johanna Calderon, France
11:30 – 11:34 FT-001 Cognitive Outcome In Fontan Patients From Preschool To School Age: Stability And Predictors, Claudia Jessen, Germany
11:34 -11:38 FT-002 Therapy Utilization In Children With Congenital Heart Disease: A Retrospective Study At The Children’s Heart Center Vienna, Anna Scholten, Austria
11:38 11:42 FT-003 Five – Year Neurodevelopment In Children With Congenital Heart Disease: Insights From A Multidisciplinary Program In Spain, Alba Mendoza Jiménez, Spain
11:42 – 11:46 FT-004 Management Of Patients With Scn5a Mutation With Possible Mixed-Phenotype, Vasiliki Tsolaki, Greece
11:46 – 11:50 FT-005 R222q Mutation Of The Scn5a Gene In Pediatric Age: Phenotype And Response To Pharmacological Therapy, Silvana Catucci, Italy
11:50 – 11:54 FT-006 Exploring Genetic Variants Associated With Pulmonary Valve Size In Tetralogy Of Fallot: A Genome-Wide Association Study, Noor Al Kharusi, Oman
11:54 -11:58 FT-007 Linking Plasma-Derived Extracellular Vesicle Micrornas To Cardiac Remodeling Mechanisms In Pediatric Congenital Heart Defects, Nesrine Farhat, Belgium
11:58 – 12:02 FT-008 ZNF516 Identified As A Novel Genetic Regulator Of Heart Development And Congenital Heart Disease, Lieke Van Roon, Netherlands
12:02 -12:06 FT-009 Male Violence Reprograms Cardiac Cell Identity, Driving Maladaptive Remodeling In Female Mice, Jacopo Agrimi, Italy
12:06 – 12:10 FT-010 Refined Clinical Diagnosis In Loeys-Dietz-Syndrome: The Need For A Distinct Nosology, Veronika Stark, Germany
12:10 – 12:14 FT-011 Cardiac Involvement In Noonan Syndrome: Genotype-Phenotype Correlations, Silvia Passantino, Italy
12:14 – 12:18 FT-012 Psychological Aspects And Mental Health Risks In Children And Adolescents With Congenital Heart Defects,L.Eliza Chiperi, Romania
12:18 – 12:22 FT-013 Double-Chambered Left Ventricle Associated With Left Ventricular Non-Compaction And An Mybpc3 Variant Presenting With Restrictive Physiology In An Adolescent, Hirokuni Yamazawa, Japan
12:22 – 12:26 FT-014 Oral Hygiene Behavior And Knowledge On Prevention Of Infective Endocarditis In Transition-Aged Adolescents With Congenital Heart Disease, Céline Steiner, Switzerland
12:26 – 12:30 FT-015 Cardiogame: A Family-Oriented Game-Based Approach To Health Education In Pediatric Congenital Heart Disease, Pia Cassanello, Spain
12:30 – 12:34 FT-016 Genetic Testing In Congenital Heart Disease: A 6-Year Neonatal Cohort Exploring Genotype–Phenotype Associations, Maxsuel Xiloj, Spain
12:34 – 12:38 FT-017 Neuroimaging Findings Before And After Cardiac Surgery In Neonates And Infants With Critical And Non-Critical Congenital Heart Disease, Cosimo Marco Campanale, Italy
12:38 – 12: 42 FT-018 Revisiting The Concept Of “Phenotype” In Pediatric Hypertrophic Cardiomyopathy Using Myocardial Stiffness And Strain Variations Assessed By Ultrafast Ultrasound Imaging, Maelys Venet, France
12:42 – 12:46 FT -019 Clinical And Echocardiographic Profile Of Pediatric Cardiomyopathies In Children In A Tertiary Care Centre In India, Nikhil Sunil, India
12:46 – 12:50 FT -020 Screening For Psychiatric Symptoms And Mental Health Support In Danish Children And Adolescents With Tetralogy Of Fallot, Sara Lau-Jensen, Denmark
12:50 – 12:54 FT -021 Efficacy Of Nadololo In Rasopathies With Obstructive Hypertrophic Cardiomyopathy: A Case Series Nicoletta Cantarutti, Italy
12:54 – 12:58 FT -022 Novel Digenic Inheritance Involving Ttn And Ctnna3 Truncating Variants In Familial Dilated Cardiomyopathy: From Acute Heart Failure To Subclinical Disease, Rania Gargouri, Tunisia
12:58 – 13:02 FT -023 Indicators Of Parental Distress After Infant Hospitalization In Paediatric Cardiac Intensive Care Units: A Two – Centre Observational Study, Katharina Schmitt, Germany
|
| 13:00 – 14:00 |
Mentoring – Small Group Discussion
(Limited Participation – Additional Registration Required) Chairs: Ruth Heying, Belgium
Navigating Paediatric Heart Failure:Mentorship Across Career Stages, Dimpna Calila Albert, Spain |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Flash Talk Session 2
Chair: Giulia Tuo, Italy & Gabrielle Hessling, Germany
14:30 -14:34 FT-024 Pharmacological Management Of Foetal Svt: A Single-Centre Retrospective Study, Ifunanya Azike, United Kingdom
14:34 – 14:38 FT-025 A Four-Year Retrospective Analysis Of Fetal Cardiology Referrals Based On National Fetal Anomaly Screening Criteria In Wales, Yağmur Önal, United Kingdom
14:38 – 14:42 FT-026 Practical Experience In Applying Real-Time Artificial Intelligence-Based Prenatal Echocardiography, Tamara Yarygina, Russia
14:42 – 14:46 FT-027 Differentiating Pseudo-Delta Waves From Typical Pre-Excitation In Post-Fontan Hlhs: A Morphological Analysis, Sookyong Sung, United Kingdom
14:46 – 14:52 FT-028 Interatrial Conduction Block In Pediatric Patients With Atrial Septal Defects, Silvia Garibaldi, Italy
14:52 – 14:56 FT-029 Right Aortic Arch With Right Ductus Arteriosus: Clinical Spectrum And Outcomes From Fetal Life To Post-Natal Follow-Up, Paola Giordano, Italy
14:56 -15:02 FT-030 Borderline Left Ventricle (Blv): A Challenge In Fetal And Postnatal Period, Olga Panagiotopoulou, United Kingdom
15:02 -15:06 FT-031 Primary Junctional Ectopic Tachycardia In Children: A 15-Year Single-Center Experience, Merve Maze Aydemir, Turkey
15:06 – 15:10 FT-032 Electrical, Mechanical, And Structural Remodeling After Cardiac Resynchronization Therapy In Pediatric And Young Adult Patients, Merve Maze Aydemir, Turkey
15:10 – 15:14 FT-033 Efficacy Of Left Cardiac Sympathetic Denervation In Catecholaminergic Polymorphic Ventricular Tachycardia During Mid- And Long-Term Follow-Up, Matthias Mueller, Germany
15:14 – 15:18 FT-034 Regional Variation In Prenatal And Neonatal Screening Outcomes For Critical Coarctation Of The Aorta In Sweden, Mats Mellander, Sweden
15:18 – 15:22 FT-035 Fetal Ventricular Outpouchings – A Center’s Experience, Maria Kiaffas, United States
15:22 – 15:26 FT-036 Prevalence Of Congenital Heart Defects In Twins: The Role Of Chorionicity And Assisted Reproduction, Lucia Viola Camilla Mauri, Italy
15:26 – 15:30 FT-037 Impact Of Electrophysiologic Study And Catheter Ablation Before Conversion To Total Cavo-Pulmonary Connection, Keiko Toyohara, Japan
15:30 – 15:34 FT-038 Optimisation Of Fetal Strain By Cmr And Its Use In Suspected Coarctation Of The Aorta, Katrin Fricke, Sweden
15:34 – 15:38 FT-039 The Added Value Of Fetal Cardiac Magnetic Resonance Imaging (4d-Flow, Black-Blood And Cine) In Prenatal Cardiac Clinical Decision-Making, Gal Sela, Netherlands
15:38 – 15:42 FT-040 A Patient With Congenitally Corrected Transposition Of Great Arteries And An Accessory Pathway That Involuted Over Time , Gabriel-Laurentiu Cismaru, Romania
15:42 – 15:46 FT-041 Empirical Ablation Points On The Coronary Ostium – Tricuspid Line For The Avnrt Rf Ablation In Children, Gabriel-Laurentiu Cismaru, Romania
15:46 – 15:50 FT-042 Two-Stage Fetal Intervention For Critical Aortic Valve Stenosis With Highly Restrictive Foramen Ovale In A Twin Pregnancy, David Kielmayer, Austria
15:50 – 15:54 FT-043 A Single-Center Case Series Of Pediatric Refractory Atrial Tachycardia Treated With Pulmonary Vein Isolation, Aycan Çelebi, Turkey
15:54 – 15:58 FT-044 A Single Centre Twenty Year Experience Of Vascular Ring Repair: Comparison With Complex Arch Repair, Frequency Of Persistent Symptoms And Rates Of Reintervention, Abigail Sharpe, United Kingdom
15:58 – 16:02 FT-220 Symptomatic Fetal Congenital Heart Disease: Pathological Characterization At Fetal Autopsy, Marny Fedrigo, Italy
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Flash Talk Session 3
Chair: Karin Tran Lundmark, Sweden & Gabriele Assenza, Italy
16:34 – 16:38 FT-046 De-Escalation Of Milrinone Using Sacubitril/Valsartan In A Child Under 1-Year With Dilated Cardiomyopathy, Teresa Brooks, United Kingdom 16:38 – 16:42 FT-047 Increased Prenatal Diagnosis Of Vascular Ring By Fetal Echocardiogram: Has It Improved Postoperative Outcomes?,Takeshi Tsuda, United States 16:42 – 16:46 FT-048 Oral Cyclosporine A Monotherapy For Kawasaki Disease With Smoldering Inflammation: A Retrospective Study On Efficacy And Coronary Outcomes, Sorachi Shimada, Japan 16:46 – 16:50 FT-049 Longitudinal Echocardiographic Severity Scoring For The Prediction Of Chronic Lung Disease Or Death In Neonates With Patent Ductus Arteriosus (Pda), Sarah Long, Germany 16:50 – 16:54 FT-050 Are Hematologic Markers Independent Predictors Of Rheumatic Heart Disease Stage In Children?, Nida Gülderen Kalay Şentürk, Turkey 16:54 – 16:58 FT-051 Machine Learning–Driven Functional Phenotyping Of Hfpef Based On Resting And Stress Echocardiography, Qingfeng Zhang, China 16:58 – 17:02 FT-052 Outcome Of Anti-Il1 Therapy For The Treatment Of Acute Myocarditis In Young Children Complicated With Lv Dysfunction, Pierluigi Zaza, Italy 17:02 – 17:06 FT-053 Early Clinical Outcomes Of Stepwise Sacubitril/Valsartan And Dapagliflozin Therapy In Postoperative Congenital Heart Disease, Pelin Ayyildiz, Turkey 17:06 – 17:10 FT-054 Profile Of Pediatric Infective Endocarditis From A Tertiary Care Centre In India, Nikhil Sunil, India 17:10 – 17:14 FT-055 Home Exercise Program For Adult Congenital Heart Disease Patients: Feasibility, Outcomes And Persistent Barriers From A Pilot Study, Navaneetha Sasikumar, Canada 17:14 – 17:18 FT-056 Predictive Value Of Inflammatory Biomarkers For Coronary Artery Involvement And Ivig Resistance In Kawasaki Disease, Timur Meşe, Turkey 17:18 – 17:22 FT-057 The Heartmate 3 Assist Device In Paediatric Cardiomyopathy: A Report From Single Cardiac Centre, Matus Kovac, Slovakia 17:22 – 17:26 FT-058 Early Il-1 Blockade With Anakinra In Paediatric Acute Myocarditis: A Single-Centre Retrospective Study, Marco Basile, Italy 17:26 – 17:30 FT-059 Reframing Exercise In Repaired Congenital Heart Disease: Cardiopulmonary Exercise Test Data Supporting Safe, Personalized Sport Participation, Lorenzolupo Dei, Italy 17:30 – 17:34 FT-060 The Molecular Microscope Diagnostic System (Mmdx-Heart) In Paediatric Heart Transplant Recipients: Comparison With Histology And Impact On Clinical Management, Karel Koubský, Czech Republic 17:34 – 17:38 FT-061 Droplet Digital Pcr For Donor-Derived Cell-Free Dna Measurement In A National Pediatric Heart Transplant Cohort, Jens Böhmer, Sweden 17:38 – 17:42 FT-062 Comprehensive Retrospective Analysis Of 104 Scimitar Syndrome Patients Over 33 Years, Hicran Gül Emral, United Kingdom 17:42 – 17:46 FT-063 Double-Orifice Tricuspid Valve: An Unusual Diagnosis In A Young Patient, Cyrine Issaoui, Tunisia 17:46 – 17:50 FT-064 Use Of Chronic Total Occlusion Techniques For Successful Stenting Of Thoracic Aortic Atresia, Claudiu Florin Rășinar, Romania 17:50 – 17:54 FT-065 Clinical Utility Of Neutrophil-To-Lymphocyte Ratio And Systemic Inflammation Response Index In Pediatric Kawasaki Disease, Burcu Acar Alkan, Turkey 17:54 – 17:58 FT-066 Attitudes Towards And Barriers Against Exercise In Adults Living With Congenital Heart Disease, Conor Gibb, UK 17:58 – 18:02 FT-067 Diagnostic Yield Of The Just Project For Early Identification Of Youth At Risk For Sudden Cardiac Death Francesca Bonanni, Italy 14:38 – 14:42 FT-114 Towards Improved Pediatric Fitness Assessment: Validation Of A Vo₂Max Z-Score Model In Healthy Spanish Children, Esteban Peiro, Spain
|
| 11:30 – 13:00 |
Genetics, Basic Science and Myocardial Disease Abstract Session
Chair: Laura Mosquera, Belgium & Sergio Laranjo, Spain
11:30 – 11:37 O-00 Prevalence and Clinical Significance of Cardiac Autoantibodies in Paediatric Myocarditis, Nele Rolfs, Germany
11:37 – 11:44 O-002 Rethinking Prognosis in Genetic Infant DCM: Long-Term Outcomes After PAB, Thushiha Logeswaran, Germany
11:44 – 11:51 O-004 Adjacent N-Terminal SCN5A Variants (Leu212Pro and Arg222Gln) and a Novel Clinical Phenotype: a Two-Family Comparative Case Report, José Luis López Guillén, Canada
11:51 – 11:58 O-005 Fibrotic Signature in the Serum Proteome of Fontan Patients – Results of a Mass Spectrometry Analysis of Extracellular Matrix Proteins, Isabel Mihajlovic, Austria
11:58 – 12:05 O-006 Congenital Long QT Syndrome – From Screening of Family Members to Sudden Cardiac Death – a Case Series, Lilia Bardarska, Bulgaria
12:05 – 12:12 O-007 The Role of Epicardium-Derived Cells in the Development of the Sinus Venosus and the Sinoatrial Node, Thomas Bos, Netherlands
12:12 – 12:19 O-008 MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies (MEKINRAS) – Preliminary Results, Maciej Kołodziej, Poland
12:19 – 12:26 O-009 ELN-Related Vascular Disease: Are We Treating Too Early?, Simon D’hulst, Belgium
12:26 – 12:33 O-010 A Novel Nonsense CAPNS1 Variant in Paediatric-Onset Pulmonary Arterial Hypertension Associated With Neurological Manifestations, Rebeca Weldeghebreal, Netherlands
12:33 – 12:40 O-011 Potential Predictors of Reverse Remodeling in Pediatric Primary Dilated Cardiomyopathy, Chiara Servoli, Italy
12:40 – 12:47 O-012Gut Microbiome in Children With Congenital Heart Disease Following Cardiopulmonary Bypass Surgery (GUMIBEAR Study) – Shotgun Metagenomic Analysis, Sean Kelleher, Ireland
12:47 – 12:54 O-013 Prevalence And Role Of Pathogenic Cardiomyopathy Gene Variants In Pediatric Biopsy-Proven Acute Myocarditis, Nicoletta Cantarutti, Italy
|
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Nursing and Allied Health Professionals Abstract Session
Chair: Yael Van Haren, Belgium & Amanda Potterton, UK
14:30 – 14:37 O-014 Parents of Children With Heart Disease; Experiences and Challenges After Long Term Hospitalization, Elin Friberg, Sweden
14:37 – 14:44 O-015 A National Review of Pharmacist Provision in Paediatric Extracorporeal Membrane Oxygenation (ECMO) in the United Kingdom (U.K.) and Ireland, Susie Gage, United Kingdom
14:44 – 14:51 O-016 Fontan Family Camp Has a Positive Impact on Psychosocial Well-Being and Human Connections, Jody Gingrich, Canada
14:51 – 14:58 O-017 Adolescents’ Opinions and Informational Needs About Sexual and Reproductive Health, Åsa Burström, Sweden
14:58 – 15:05 O-018 Perceived Barriers and Facilitators for Implementing Family-Centered Clinical Rounds in Pediatric Cardiology, a Health Care Professionals Survey, Josien Klein & Isabel Jessurun-Olivieira, Netherlands
15:05 – 15:12 O-019 Development of Medical Digital Technology to Support Self-Reliance–Promoting Activities for Patients Including Congenital Heart Disease, Atsuhito Takeda, Japan
15:12 – 15:19 O-020 Listening to Their Voices: Strengths and Support Needs of Individuals With Congenital Heart Disease, Down Syndrome, and Both Conditions, Marcia Van Riper, United States
15:19 – 15:26 O-021 Effects of Preoperative Nutrition-Based Interventions on Pre-, Intra-, and Postoperative Outcomes in Children Undergoing Cardiac Surgery: a Systematic Review and Meta-Analysis, Maciej Kołodziej, Poland
15:26 – 15:33 O-022 Care Closer to Home: a Regional Project Report From the United Kingdom, Susana De Sousa, United Kingdom
15:33 – 15:40 O-023 When Seconds Matter: Paediatric Basic Life Support Training for Families of Children With Heart Disease, Helena Roos, Sweden
15:40 – 15:47 O-024 Response to Increased CLABSI in PICU Through Simulation-Based Interventions, Faryal Kanwal, Pakistan
15:47 – 15:54 O-025 Children and Youth With Heart Disease in Focus – an Intervention to Increase Person-Centeredness in Highly Specialized Care, Marina Björk, Sweden
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Neurodevelopment and Psychosocial Care & Paediatric Cardiovascular Intensive Care Abstract Session
Chair: Frank Casey, USA & Angelica Weber, UK
16:30 – 16:37 O-038 Integrating Polygenic and Clinical Risk: Predicting ADHD and Autism in Individuals With Congenital Heart Defects, Sara Lau-Jensen, Denmark
16:37 – 16:44 O-039 Neurodevelopmental Screening in Children With Congenital Heart Disease: The Necker Children’s Hospital Cardiac Neurodevelopmental Center Follow-Up, Johanna Calderon, France
16:44 – 16:51 O-040 Examining Neuropsychological Outcomes and Neural Correlates of Children Diagnosed With Congenital Heart Disease and Children Born Very Preterm, Samantha Roberts, Canada
16:51 – 16:58 O-041 Long-Term Neurodevelopment After Pediatric Cardiac Arrest: Trajectories, Individual Outcomes, and the Role of Interdisciplinary Follow-Up, Lucy Liem, Germany
16:58 – 17:05 O-042 Vineland-II Adaptive Behavior Scales and Neurodevelopmental Catch-Up in Fontan Patients: Who Can Catch Up?, Shin Ono, Japan
17:05 – 17:12 O-043 Cardiopulmonary Fitness and Emotional Concerns in Fontan Youth, Haley Forbes, United States
17:12 – 17:19 O-044 Biomarker-Based Neurologic Prognostication After Pediatric Cardiac Arrest: Clinical Predictors, Feasibility and Outcomes in a Pediatric Cardiology Cohort, Lucy Liem, Germany
17:19 – 17:26 O-045 Inhaled Nitric Oxide via High-Flow Nasal Cannula in Post-Repair Congenital Heart Disease Patients With Pulmonary Hypertension After Extubation: a Cohort Study With Propensity Score Matching, Xiaofeng Wang, China
17:26 – 17:33 O-046 Neurodevelopment in Children With Severe Congenital Heart Defects; Relation With Prenatal Parameters, Victorien Luppes, Netherlands
17:33 – 17:40 O-047 Prevalence and Risk Factors of Post-Traumatic Stress Symptoms and Anxiety in Parents of Children With Congenital and Acquired Heart Diseases, Neil Derridj, France
17:40 – 17:47 O-048 Iatrogenic Withdrawal Syndrome (IWS) Has a Specific Risk Profile in Children After Cardiac Surgery, Ida Hüners, Germany
17:47 – 17:54 Use Of Epoprosterenol In Perioperative Period In Patients With Congenital Heart Surgery, Pelin Ayyildiz, Türkiye
|
| 13:15 – 14:15 |
Session 1 – Fontan (Totem 1)
Chair: Esme Dunne, Ireland & Elena Cuppini, Italy
MP-002 Long-Term Outcomes And Exercise Capacity In Ecc-Tcpc Patients: Impact Of Conduit Size And Temporal Changes, Laura Büscher, Germany MP-003 Do Sublingual And Peripheral Skin Venous Malformations Predict The Incidence And Severity Of Long-Term Fontan Associated Complications? A Case Report, Rajendra Raghuraman, UK MP-004 Is Iron Deficiency A Risk Factor For Adverse Events In Adult Patients With Fontan Circulation?,Elettra Pomiato, Italy MP-005 Exploring The Cardiac-Renal Relationship In Fontan Patients: Implications For Clinical Follow Up, Roberta Biffanti, Italy MP-006 Cardiac Resynchronization Therapy With Physiology-Based Single-Site Ventricular Pacing In Children With Univentricular Physiology: A Three-Case Series, Yasufumi Kittaka, Japan MP-007 Prediction Of Need For A Permanent Pacemaker In Children And Adults With Left Atrial Isomerism In A Univentricular Pathway, Conor Gibb, United Kingdom MP-008 Lung Perfusion Imaging In Patients With Fontan Circulation Using Contrast-Free Arterial Spin Labeling Mri, Anja Hanser, Germany MP-009 Longterm Outcomes And Lymphatic Complications After Total Cavopulmonary Connection: A Single-Center Cohort Study Jan Hinnerk Hansen, Germany MP-011 Rivaroxaban Therapy For Ventricular Thrombus In Hypoplastic Left Heart Syndrome: A Case Report, Luiza Sulej, Poland MP-012 Switching To Direct Oral Anticoagulants In Children With Fontan Circulation, Inna Trunina, Russia MP-013 Non-Invasive Evaluation Of Fontan-Associated Liver Disease In Children: Longitudinal Performance Of Transient Elastography And Apri In A Single-Centre Cohort, Wisam Abozaid, Canada MP-015 Thyroid-Gut-Axis Abnormalities In Fontan Patients: A Report From The Fontan Care Network, Floris Udink ten Cate, Netherlands MP-016 The Clinical Implications Of Renal Doppler Ultrasonography For Predicting Chronic Kidney Disease And Fontan Failure, Raffaella Marzullo, Italy MP-017 Determinants Of Exercise Capacity In Fontan Patients, Isabelle Schöffl, Germany MP-018 Stroke Volume Augmentation Is The Main Predictor Of Peak Oxygen Consumption In Children And Adolescents With Fontan Circulation, Paola Dolader-Codina, Spain |
| 13:15 – 14:15 |
Session 2 – Invasive Treatments (Totem 2)
Chair: Ali Dodge-Khatami, Germany & Giuseppe Santoro, Italy
MP-020 Fifteen-Year Outcomes Of 12 Mm Bovine Jugular Vein Conduits Versus Small Homografts For Right Ventricular Outflow Tract Reconstruction In Neonates, Ivan Kozyrev, Germany MP-021 Prevalence And Timing Of Acute Kidney Injury After Pediatric Cardiac Surgery, Louisa Bode, Germany MP-023 Covid-19 Pandemic And The Service Of Congenital Heart Surgery In Lithuania: Intermediate Follow-Up Results Of Infants Who Underwent Non-Palliative Correction Of Low And Medium Complexity Congenital Heart Disease, Dominykas Budrys, Lithuania MP-024 Use Of Decellularized Equine Pericardium For Cardiac Defect Repair: Mid- And Long-Term Outcomes In 388 Patients, , Walid Bennour, Germany MP-026 The Use Of Cutting Balloons In The Treatment Of Resistant Peripheral Pulmonary Stenosis Following Surgical Treatment Of Congenital Heart Defects, Jacek Kusa, Poland MP-027 Konar Mfo Occluder– New Device For Multiple Purposes, Roland Fiszer, Poland MP-028 Success Rate Of Catheter Balloon Dilations And Outcomes In Pediatric Patients With Congenital Pulmonary Stenosis – Single Center Cohort 2011-2024, Asaf Ta-Shma, Israel MP-029 Efficacy And Safety Of Transcatheter Closure Of Atrial Septal Defects Using The Amplatzer Septal Occluder Versus The Cocoon Septal Occluder: A Retrospective Multicenter Study, Basil (Vasileios) Thanopoulos, Greece MP-031 Breaking The Block: Successful Radiofrequency Recanalization Of Superior Vena Cava Obstruction After Glenn Takedown, Maxsuel Xiloj, Spain MP-032 Melody Valve Implantation In Patients With 22q11 Anomaly – Is There A Higher Risk Of Infective Endocarditis?, Roland Gitter, Austria MP-033 Clinical Outcomes Of Percutaneous Pfo Closure Using A Single Occluder: A Single-Center Experience, Massimiliano Cantinotti, Italy MP-035 Percutaneous Neck Cannulation In Infants: A Safe, Feasible, And Effective Alternative For Reliable Vascular Access In Va-Ecmo?, Julia Danner, Germany MP-036 Virtual 3d Planning Of Heartmate 3 Implantation In Pediatric Patients Using Ct-Based Anatomical Modelling, Lorena de Oliveira López, Spain MP-206 Initial Monocentric Experience With A New Bioresorbable Stent For Patent Ductus Arteriosus (Pda) Stenting In Neonates With Duct-Dependent Pulmonary Circulation Francesco Prati, Italy MP-207 Advanced Lymphatic Imaging And Interventions In Patients With Severe Lymphatic Complications: A Case Series With Up To Four-Year Outcomes, Sanam Safi-Rasmussen, Denmark |
| 13:15 – 14:15 |
Session 3 – Fetal, Perinatal and Maternal Cardiology (Totem 3)
Chair: Andreas Tulzer, Austria & Elena Reffo, Italy
MP-038 Outcome Of Pregnancy In A Cohort Of Women With Congenital Heart Disease- A- 23 – Year, Single-Center Experience, Ylenia Bartolacelli, Italy MP-040 First In-Fetal Use Of An Everolimus-Eluting Stent In A Fetus With Hlhs With Intact Atrial Septum, Florian Putre, Austria MP-043 Evolving Practice Of Genetic Testing In Antenatal And Post-Natal Diagnosis Of Major Congenital Heart Diseases In A Tertiary Centre, Justin Ng Choon Hwee, Singapore MP-045 Early Foetal Diagnosis Of Single-Ventricle Physiology Compared With Standard Foetal Diagnosis, Gerald Riordan, Australia MP-047 Determining The Impact Of Remoteness Of Residence And Lower Socioeconomic Status On Access To Fetal Echocardiography In Saskatchewan, Canada, Timothy Bradley, Canada MP-048 Cross-Cultural Adaptation Of A Prenatal Counseling Questionnaire For Congenital Heart Disease In Brazil, Luciane Amorim, Brazil MP-049 Impact Of Maternal Polycystic Ovary Syndrome On The Structure And Function Of The Newborn Heart: A Copenhagen Baby Heart Study, Anna Rathsach Strange, Denmark MP-050 Impact Of Preterm Birth On Diastolic Function In Newborns, Marie Højgaard Andersen, Denmark MP-051 Maternal And Fetal Outcomes After The Ross Procedure, Valeria Pergola, Saudi Arabia MP-053 Genetic And Cardiac Discordance In Twin Pairs, Nurdan Erol, Turkey MP-073 Opm-Based Fetal Magnetocardiography: Fetal Cardiac Time Intervals In Healthy Pregnancies Compared To Postnatal Ecgs, Karin Narushima, Germany MP-201 Fetal Heart Global Sphericity Index And Global Longitudinal Strain After A Fetal Tachyarrhythmia– A Case Series,Carla Blunt, UK MP-202 Placental And Umbilical Cord Anomalies In Hypoplastic Left Heart Syndrome And Transposition Of The Great Arteries,Sofia Grinenco, Argentina MP-208 The Challenge Of Prenatal Diagnosis Of Hypoplastic Left Heart Syndrome: Life Beyond Surgery?, Cristina Cadonati, Italy MP-209 Predictive Value And Clinical Impact Of Fetal Echocardiography In The Diagnosis Of Congenital Heart Diseases With Left Ventricular Outflow Tract Obstruction: Eight Years Of Experience At A Tertiary Referral Center,Gabriella Gaudieri, Italy |
| 13:15 – 14:15 |
Session 4 – Clinical Cardiology (Totem 4)
Chair: Henk Schipper, The Netherlands & Martina Avesani, Italy
MP-055 Prevalence And Characteristics Of Weight Loss Medication Use Among Adults With Congenital Heart Disease: A Danish Cohort Study, Chee Woon Lim, Denmark MP-056 Multimodal Deep Learning Model Integrating Chest X-Rays And Clinical Features For Noninvasive Prediction Of Qp/Qs In Children With Congenital Heart Disease, Teruyoshi Shimoyama, Japan MP-057 Lessons Learned: Estsblishing Basic Pediatric Cardiology Services In Thakhek, Laos, Ruth Deindl, Germany MP-060 Prevalence Of Nasopharyngeal Carriage, Serotype Distribution And Antibiotic Susceptibility Of Streptococcus Pneumoniae Among Children With Congenital Heart Disease And Pneumonia, Sanmeet Kaur, India MP-061 Venous Stiffening Is Compensatory Mechanism Against Compromised Cardiac Reserve In The Children With Congenital Heart Disease – A Novel Marker Of Cardiovascular Remodeling And End Organ Damage, , Yu Matsuo, Japan MP-062 Impact Of Corticosteroid Therapy On Blood Pressure And Autonomic Function In Duchenne Muscular Dystrophy, Madiha Mohammadi, Poland MP-063 Recurrent Episodes Of Troponinemia And Atypical Chest Pain As An Indication Of A Genetic Substance In A Young Adolescent, Aikaterini Giannakopoulou, Greece MP-064 Blood, Growth, And Performance: Developmental Hemoglobin Patterns In Competitive Youth Athletes, Sebastian Freilinger, Germany MP-065 Multidimensional Assessment Of Motor Skills, Physical Activity, Wearable Accuracy In Children With Congenital Heart Defects And Chronic Diseases, Christina Sitzberger, Germany MP-066 Singing As Respiratory Physiotherapy? Breathing-Training Intervention In Congenital Heart Disease: A Pilot Study, Lamia Ait Ali, Italy MP-067 Dynamic Hyperinflation During Exercise In Patients With Congenital Heart Disease And Healthy Controls – A Cross-Sectional Study, Viktoria Ludwig, Germany MP-068 Systematic Review On Exercise Prescription In Children With Heart Disease, Arnav Rustogi, United Kingdom MP-069 The Impact Of Physical Activity Level On Cardiorespiratory Fitness In Patients With Congenital Heart Diseases Across Competitive Sport Classes, Emiliano Scettri, Italy & Gino Degano, Italy MP-070 Cardiac Recovery, Functional Improvement, And School Reintegration With Elamipretide In Barth Syndrome, Pascal Amedro, United Statess MP-210 The Utility Of B-Type Natriuretic Peptide (Bnp) As A Bio-Clinical Marker In The Follow-Up Of Patients Palliated With Fontan Circulation For Univentricular Heart Disease, Abdulla Tarmahomed, United Kingdom |
| 13:15 – 14:15 |
Session 5 – Intensive Care and NDV (Totem 5)
Chair: Bea Latal, Switzerland & Dimpna Calila Albert, Spain
MP-074 Knowledge And Attitudes Of Parents Of Children With Congenital Heart Disease, Ageliki Karatza, Greece MP-075 Brain Volume Development And Aortic Flow Alterations In Fetal Lambs With Induced Hypoplastic Left Heart Syndrome, Walter Knirsch, Switzerland MP-076 Online Choir Overcomes Geographical Barriers And Fosters Connection Among Children With Congenital Heart Disease, Edythe Tham, Canada MP-077 When Hearts Get Complicated: How Chd Severity Shapes Emotion Regulation Benefits In Youth, Katya De Groote, Belgium MP-078 Identifying Autonomy-Supportive Coaching Behaviors In An Executive Function Intervention For Children With Complex Congenital Heart Disease: A Qualitative Analysis, Alenka Schmid, Switzerland MP-079 Feasibility And Impact Of A Digital Matching Tool For One To One Peer Support For Caregivers And (Young) Adults With Congenital Heart Disease In The Netherlands Ilse Hornes, Netherlands MP-080 Prognostic Value Of The Neutrophil-To-Lymphocyte Ratio As A Perioperative Biomarker In Pediatric Cardiac Surgery, Manuela Lopes, Portugal MP-081 An Exploratory Study Of Landiolol Plus Amiodarone Versus Amiodarone Monotherapy In Paediatric Junctional Ectopic Tachycardia After Surgery Maria Sandoval Franco, Germany MP-082 Angiotensin Ii For Recalcitrant Vasoplegia In A Postoperative Norwood Neonate: Examination Of At-Ii Use Cases In The Cardiac Icu, Michael Kim, United States MP-083 Is Bedside Echoguided Transcatheter Pda Closure An Accepted Therapy?, Dunja Renner, Germany MP-084 Single Center Outcome Of Patients Undergoing Extracorporal Membrane Oxygenation After Neonatal Norwood Procedure, Daria Sumbadze, Germany MP-085 Predictors For Prolonged Intensive Care Unit Stay Following Cardiac Surgery Among Pediatric Patients With Down Syndrome: A Single-Centre Experience, Putri Yubbu, Malaysia MP-088 Body & Mind: Holistic Screening And Early Intervention Program For Children And Adolescents Who Have Undergone Cardiac Surgery, , Lisa Gebert, Germany MP-203 Brain Injury Patterns In Preterm Infants With Congenital Heart Disease And Necrotizing Enterocolitis, Marta Camprubí Camprubí, Spain MP-204 Massive Pulmonary Embolism And Direct Oral Anticoagulants: New Perspectives In The Pediatric Population, Erilda Topuzi, Italy |
| 13:15 – 14:15 |
Session 6 – Tronco-Conal Diseases (Totem 6)
Chair: Benedetta Leonardi, Italy & Inga Voges, Germany
MP-090 Predictors Of Mortality In Patients With Congenitally Corrected Transposition Of The Great Arteries: A Single-Center Retrospective Study, Imane Boualaoui, Tunisia MP-091 Management And Outcomes Of Congenitally Corrected Transposition Of The Great Arteries: A Single-Center Experience, Ella Lahmaier, Tunisia MP-092 Mr T1 And T2 Mapping Of The Heart And Liver In Repaired Tetralogy Of Fallot, Jacob Söderman, Sweden MP-093 A Study Of The Cardiac Anatomical And Hemodynamic Interplay In A Porcine Model Of Repaired Tetralogy Of Fallot, Anouk Moerdijk, Netherlands MP-094 Cmr-Derived Left Atrial Function In Congenitally Corrected Transposition Of The Great Arteries: A Marker Of Diastolic Impairment, Maria Felicia Gagliardi, Italy MP-095 A Comparison Of Three-Dimensional Echocardiography And Cardiac Magnetic Resonance Imaging In The Evaluation Of The Right Ventricle In Patients With Surgically Repaired Tetralogy Of Fallot, Boran Cakan, Turkey MP-096 Pulmonary Atresia In Congenital Heart Defects: Can We Deduce Embryological Mechanisms From Morphological Phenotype?, Jeanne Mechin, France MP-097 Tetralogy Of Fallot With Abnormal Coronary Artery: Surgical Management And Long-Term Results, Benedetta Leonardi, Italy & Inga Voges, Germany MP-098 Effect Of Prior Balloon Atrial Septostomy On Mortality Outcomes In Neonates With D-Transposition Of The Great Arteries Undergoing Arterial Switch Surgery: A Systematic Review And Meta-Analysis, Mohammed Ahmed Mohammed, Somalia MP-099 Long-Term Outcome Of An Arterial Switch Operation In Patients With Taussig-Bing Anomaly, Krzysztof Michalak, Poland MP-100 Assessment Of Systemic Right Ventricular Function: Senning Procedure Versus Congenital Corrected Transposition Of The Great Arteries, Valentyna Khanenova, Ukraine MP-101 From Prenatal Diagnosis To Heart Transplantation In A 2-Month-Old Infant”, Magdalena Żak, Poland MP-102 Fetal Mri And Echocardiographic Changes With Acute Maternal Hyperoxygenation In Transposition Of The Great Arteries, Sophie Duignan, United Kingdom MP-103 A Rare Case Of Transient Left Ventricular Systolic Dysfunction After Percutaneous Venusp-Valve Implantation In A 14-Year-Old Boy With Tetralogy Of Fallot, Dawid Jasiński, Poland MP-104 Neurodevelopment Outcomes Associated With Changes In Oxygenation In Newborns With Transposition Of The Great Arteries, María Clara Escobar Díaz, Spain/em> MP-205 Exercise Modality–Related Differences In Cpet Parameters In Patients With Repaired Tetralogy Of Fallot, Benedetta Leonardi, Italy |
| 08:00 – 09:00 | Paediatric Cardiovascular Intensive Care WG Business Meeting |
| 09:00 – 10:30 |
Redefining Pediatric Cardiac Intensive Care Education: Technology, Innovation & Collaboration Chairs: Dimpna Albert-Brotons, Spain & Ruth Heying, Belgium 09:00 – 09:18 Simulation-Based Learning in Pediatric Cardiac ICUs: Building Competence Before the Crisis, Ulrich Krause, Germany |
| 10:30 – 11:00 | BREAK |
| 11:00 – 11:30 |
Hausdorf Lecture Chairs: Thomas Krasemann, The Netherlands & Shakeel Qureshi, UK From Idea to Daily Clinical Practice, Eric Rosenthal, UK |
| 11:30 – 13:00 |
Digital, OMICS Profiling & Predictive Analytics for Paediatric Inherited Cardiovascular Conditions Chairs: Sergio Laranjo, Portugal & Eugenio Baraldi, Italy 11:30 – 11:52 Omics-guided Target Discovery and Early-intervention Trials in Marfan, Laura Muino-Mosquera, Belgium |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Virtual or Reality – A Dig Deeper Chairs: Giuseppe Limongelli, Italy & Kalliopi Pilichou, Italy 14:30 – 14:52 Genetic Treatment for CHD. Where Are We and Where Do We Go?, Georgia Sarquella Brugada, Spain |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
3D Printing and VR – The Future of Imaging in CHD Chairs: Thomas Salaets, Belgium & Biagio Castaldi, Italy 16:30 – 16:52 Complex Congenital Cardiac Repairs Warrant 3D Printed Models for Planning – PRO,Colin McMahon, Ireland |
| 08:00 – 09:00 | Cardiac Imaging WG Business Meeting |
| 09:00 – 10:30 | Joint Session JSPCCS – AEPC
Hypoplastic Left Heart Syndrome from the Fetus, Throughout the Fontan Palliation
Chairs: Hiroshi Ono, Japan & Jan Janousek, Czechia
09:00 – 09:22 In Utero Intervention in Hypoplastic Left Heart Diseases: Where Are We Now?, Andreas Tulzer, Austria
09:22 – 09:44 Norwood Procedure Variants, Hot to Choose Among Them, Takahisa Sakurai, Japan
09:44 – 10:06 Old and New Therapeutical Options for PLE and Fontan Failure, Takayuki Oyanagi, Japan
10:06 – 10:28 Creation of a Fontan Fenestration,Enrico Picinelli, Italy
|
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 |
AV Valves and the Myocardium: A Two-sided Story Chairs: Giovanni Di Salvo, Italy & Stephen Sanders, USA 11:30 – 11:52 Embryology of the Atrio-ventricular Valves, Stephen Sanders, USA |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Advanced Imaging in Electrophysiology and Cardiac Devices Chairs: Ulrich Krause, Germany & Sylvia Krupickova, UK 14:30 – 14:52 Intracardiac Echocardiography to Guide Paediatric EP and CHD Ablations, Laszlo Kornyei, Hungary |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
ECG Quiz Chairs: Massimo Silvetti, Italy |
| 08:00 – 09:00 | Congenital Heart Surgery WG Business Meeting |
| 09:00 – 10:30 |
The Lymphatic System – Why Bother Chairs: Marc Gewillig, Belgium & Vibeke Hjortdal, Denmark 09:00 – 09:18 Lymphatic Drainage: The Importance for CHD and Heart Failure, Benjamin Kelly, Denmark |
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 |
EACTS/ECHSA – AEPC Joint Session 11:30 – 11:52 The New Burden of Ventricular Failure, Karel Koubský, Czechia 11:52 – 12:14 Modern Results of Post-Cardiotomy ECMO, Attilio Lotto, UK 12:14 – 12:36 Berlin Heart – EXCOR Results, Rudolf Poruban, Czechia 12:36 – 12:58 Ped-Impella, Bart Meyns, Belgium |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 | Congenital Heart Surgery Abstract Session
Chair: Rudolf Poruban, Czechia & Hitendu Dave, Switzerland
14:30 – 14:37 O-074 Successful Long Term Outcome Of Cabg In Paediatric Patients: A Retrospective Analysis At A Tertiary Centre, Riyanka Gupta, United Kingdom
14:37 – 14:44 O-075 Long Term Ventricular Assist Devices In Children And Congenital Adults: 20 Years Of Experience., Bunty Ramchandani, Spain
14:44 – 14:51 O-076 Long-term Outcomes After Pediatric Epicardial Pacing: Critical Impact Of Surgical Access And Ventricular Lead Position Over Time, Uladzislau Kolbik, Belarus
14:51 – 14:58 O-077 Clinical Outcomes Of Tricuspidization Repair For Congenital Bicuspid Aortic Valve Malformation In Children, Yanbing Ma, China
14:58 – 15:05 O-078 Toward Prediction Of Mitral Valve Repair Using Patient-specific Fluid-structure Interaction Modeling, Nina Hakacova, Sweden
15:05 – 15:12 O-079 Surgical Management Of Ascending Aortic Aneurysm In Patients With Genetic Connective Tissue Disorders, Merlin Lemke, Germany
15:12 – 15:19 O-080 Results And Long-term Outcomes Following Surgical Decompression Of Vascular Rings With Or Without Concomitant Tracheal Surgery, Andrea Linnenbank, Germany
15:19 – 15:26 O-081 Modeling First-stage Hypoplastic Left Heart Syndrome Strategies Using A Zero-dimensional Closed-loop Framework, Aseem Milind Pradhan, France
15:26 – 15:33 O-082 Early Repair Of Truncus Arteriosus Is Associated With Fewer Preoperative Complications And Comparable Postoperative Outcomes, Patrizio Moras, Italy
15:33 – 15:40 O-083 Mechanical Prostheses For Valve Replacement In Children: A Lifelong Challenge, Eline-Alice Brys, Belgium
15:40 – 15:47 O-084 Circle Of Willis Variants And Their Association With Congenital Heart Disease And Postoperative Brain Injury, Judit Alsina Rossell, Spain
15:47 – 15:54 O-085 Early Repair Of Truncus Arteriosus Is Associated With Fewer Preoperative Complications And Comparable Postoperative Outcomes Eva Sames-Dolzer, Austria
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Knowledge Transfer in Low-and-Middle Income Countries
Joint WG: Congenital Heart Surgery & Nursing and Allied Health Professionals & Pulmonary Hypertension, Heart Failure and Transplantation
Chairs: Massimo Chessa, Italy & Chantal Etter, Switzterland
16:30 – 16:52 CHD Treatment. Knowledge Transfer as Experienced from The Receiver Side, Michael O’Ketcho, Uganda
16:52 – 17:14 Transferring Nursing Knowledge Between UK and LMIC is A Two Way Process, Lynda Shaughnessy, UK & Mohamed Elkhatib, Egypt
17:14 – 17:36 How To Teach Interventional Treatment in LMIC, Alan Magee, UK
17:36 – 17:58 Organising CHD Missions in LMIC, Giovanni Stellin, Italy
|
| 08:00 – 09:00 | Cardiovascular Morphology WG Business Meeting |
| 09:00 – 10:30 |
Meet the Morphologists Chairs: Nikola Topuzov, Poland & Marny Fedrigo, Italy 09:00 – 09:22 Case 1, Matthias Sigler, Germany |
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 |
ASD Closure – What’s New? Chairs: Petra Loureiro, Portugal & Mario Carminati, Italy 11:30 – 11:48 Ten Years of Sinus Venosus ASD Closure: Where Are We?, Clément Batteux, France |
| 13:00 – 14:30 |
Young Minds Meet the Experts Chairs: Sara Moscatelli, Italy & Enrico Piccinelli, Italy 13:00 -13:11 Cardiac Imaging Working Group, John Simpson, UK |
| 14:30 – 16:00 | Young Investigator Award
Chair: Werner Budts, Belgium & Mikiko Ishido, Japan
14:30 – 14:45 O-086 Risk Factors For The Development Of Prosthetic Valve Thrombosis After Systemic Atrioventricular Valve Replacement In Pediatric Patients With A Functional Single Ventricle, Yuya Yamada, Japan
14:45 – 15:00 O-087 A Biopsychosocial Model For Understanding Early Neurodevelopmental Vulnerability In Children With Congenital Heart Defects, L.Eliza Chiperi, Romania
15:00 – 15:15 O-088 Nationwide Observed Prevalence, Trends, And Future Projections Of Congenital Heart Disease In Japan: An 8-Year Registry-Based Population Analysis In A Declining-Birth Society, Tadashi Inoue, Japan
15:15 – 15:30 O-089 Yield Of Clinical Screening In Paediatric First-Degree Relatives Of Patients With Desmosomal Cardiomyopathy, Sara Moscatelli, UK
15:30 – 15:45 O-090 Association Between Blood Biomarkers And Hemodynamic Parameters In Adolescents And Adults After The Fontan Procedure: A Retrospective Cohort Study, Kentaro Kogawa, Japan
15:45 – 16:00 O-091 Longitudinal Assessment Of Cardiac Function After Craniospinal Irradiation In Pediatric Central Nervous System Tumor Survivors, Alice Pozza, Italy
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
Puzzle The Juniors – Rapid-fire Cases Chairs: Enrico Piccinelli, Italy & Marco Alfonso Perrone, Italy 16:30 – 16:52 Dilemmas: Thinking Fast & Slow, Ronel Talker, UK |
| 08:00 – 09:00 | Genetics, Basic Science and Myocardial Disease WG Business Meeting |
| 09:00 – 10:30 |
Frailty in Pediatric Patients with Congenital and Acquired Heart Disease Chairs: Maria Giovanna Russo, Italy & Kostas Dimopoulos, UK
09:00 – 09:22 Translation of Frailty Paradigm From Adults to Children with CHD, Katya De Groote, Belgium |
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 |
Surgical Therapy of Congenital Heart Disease – An Interdisciplinary Collaboration Chairs: Ricardo Munoz, USA & Dimpna Calila Albert, Spain
11:30 – 11:52 Risk Scoring and Assessment, Ferran Espuny-Pujol, UK |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 |
Cardiotoxicity and Heart Failure Chairs: Thomas Möller, Norway & Biagio Castaldi, Italy
14:30 – 14:52 Cardiotoxicity – Mechanisms and Extent of Problem, Milind Chaudhari, UK |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 |
(P)rehabilitation for Pediatric Heart Transplantation Patients: Prevention at Work Chairs: Valeria Pergola, Saudi Arabia & Henk Schipper, The Netherlands
16:30 – 16:52 The Potential Role of Mechanical Support in Prehabilitation, Gino Gerosa, Italy |
| 08:00 – 09:00 | Nursing and Allied Health Professionals WG Business Meeting |
| 09:00 – 10:30 | Challenging Practical Solutions – How to Improve Care and Patient Flows Chairs: Lynda Shaughnessy, UK & Jennie Ryan, Ireland 09:00 – 09:22 Resuscitation Education for Parents of Children with High Risk for Cardiac Arrest, Helena Roos, Sweden |
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 | Florence Nightingale Lecture Chair: Lynda Shaughnessy, UK Mind the Gaps: Understanding Nursing Science, Bridging Practice, and Supporting Lifelong Transitions in Congenital Heart Disease, Ewa-Lena Bratt, Sweden |
| 13:00 – 14:30 | Train the Trainer – How to Become Educated As A Valuable Trainer? Chairs: Merja Kallio, Finland & Melina Winkler, Austria 13:00 – 13:22 Train The Trainer – General Thoughts, Ruth Heying, Belgium |
| 14:30 – 16:00 | Communication Challenges and Solutions in Diverse and Vulnerable Populations: Advantages and Limitations of AI Chairs: Frank Casey, Belgium & Michèle de Hosson, Belgium 14:30 – 14:52 Communication with Vulnerable Populations: Strategies for Engagement and Inclusion, Bea Latal, Switzerland 15:36 – 16:00 Panel Discussion with Speakers & Audience |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 | Navigating Pregnancy with CHD: Risks, Management and Outcomes Chairs: Malin Berghammer, Sweden & Pier Paolo Bassareo, Ireland 16:30 – 16:52 Genetic Roadmaps: Preconception Screening and Congenital Heart Disease, Jolanda Sabatino, Italy |
| 08:00 – 09:00 | Sports Cardiology, Physical Activity and Prevention WG Business Meeting |
| 09:00 – 10:30 | Flash Talk Session 4
Chair: Domenico Sirico, Italy & Joeri Van Puyvelde, Belgium
09:00 – 09:04 FT-068 Pre-Procedural 3d Modelling And Guided Percutaneous Pulmonary Artery Banding In A 1-Month-Old Infant With Tricuspid Atresia, Stasa Krasic, Serbia
09:04 – 09:08 FT-069 Incidence And Treatment Of Postoperative Acute Kidney Injury Following Congenital Heart Surgery, Helene Wendt, Germany
09:08 – 09:12 FT-070 Clinical Outcome Following Repair Of Total Anomalous Pulmonary Venous Connection: Comparison Of Biventricular And Single-Ventricular Patients, Viola Kellerer, Germany
09:12 – 09:16 FT-071 Early Outcomes Of Perventricular Device Closure Of Ventricular Septal Defect Through Partial Lower Sternotomy: A Single-Centre Retrospective Study, Varsha Walavalkar, India
09:16 – 09:20 FT-072 Impact Of Surgical Exposure And Anastomotic Techniques On Outcomes In Infracardiac Total Anomalous Pulmonary Venous Connection: Insights Into The Mechanisms Of Postoperative Pulmonary Vein Obstruction, Dongdong Wu, China
09:20- 09:24 FT-073 Tetralogy Of Fallot Repair With Creation Of A Neopulmonary Valve From Autologous Right Atrial Appendage, Fabrizio Gandolfo, Italy
09:24 -09:28 FT-074 Growth Potential Of The Pulmonary Valve Annulus Following Valve-Sparing Repair In Tetralogy Of Fallot, Aws Al-Farsi, Oman
09:28 – 09:32 FT-075 Durability And Elongation Of Artificial Chords In Pediatric Mitral Valve Repair: A Comprehensive Echocardiographic Analysis, Emmanuelle Fournier, Canada
09:32 – 09:36 FT-076 Surgical Outcome And Mid-Term Follow Up Of Patients With Shone’s Complex, Walter Knirsch, Switzerland
09:36 – 09:40 FT-077 Reintervention In Neonates With Symptomatic Tetralogy Of Fallot – A Swedish Nationwide Study Comparing Different Management Strategies, Marie Bartos, Sweden
09:40 – 09:44 FT-078 Cardiac Interventions Performed In Individuals Up To 35 Years Of Age With Down Syndrome And Congenital Heart Disease, Orla Megraw, United Kingdom
09:44 – 09:48 FT-079 First European Report Of Partial Heart Transplantation As An Alternative To Valve Replacement In Complex Congenital Heart Disease, Julie Wacker, Switzerland
09:48 – 09:52 FT-080 Ductal Stenting Versus Aorto-Pulmonary Shunt For Lesions With Duct-Dependent Pulmonary Blood Flow: A Systematic Review And Meta-Analysis, Huzeifa Elhedai, United Kingdom
09:52 – 09:56 FT-081 Percutaneous Edge-To-Edge Repair For Systemic Atrioventricular Valve Regurgitation In Patients With Congenital Heart Disease: The First Descriptive Cohort, Patrice Guerin, France
09:56 – 10:00 FT-082 Establishing A Regional Multidisciplinary Single-Ventricle Care System: Rationale, Structure, And Initial Results, Anton Avramenko, Russia
10:00 – 10:04 FT-083 When The Septum Restricts: Predictors And Outcomes Of Atrial Septectomy In Fontan Patients, Saad Ahmad Malik, United Kingdom
10:04 – 10:08 FT-084 Atrioventricular Septal Defect Repair: Does Trisomy 21 Alter The Long-Term Course?, Teresa Helbing, United States
10:08 – 10:12 FT-085 Transcatheter And Hybrid Closure Of Muscular Ventricular Septal Defects Using The Konar-Mf™ Occluder: A Multicenter Pediatric Experience In India, Usha Sastry, India
10:12 – 10:16 FT-086 Use Of Impella Device In A Paediatric Hospital Over 9 Years, Lisa Bianco, Italy
10:16 – 10:20 FT-087 Interstage Outcomes In Single Ventricle Neonates: Ductal Stenting Versus Modified Blalock-Taussig Shunt, Neil Derridj, France
10:20 – 10:24 FT-088 Impact of Extracorporeal Membrane Oxygenation (Ecmo) On Morbidity, Mortality and Neurodevelopmental Outcome In Young (Walter Knirsch, Switzerland
10:24 – 10:30 FT-089 When Time Matters: Early Catheterization As A Determinant Of Recovery After Congenital Heart Surgery,Nujin Uluğ Murt, Türkiye
10:30 -10:34 FT-221 Systematic Review And Meta-Analysis Of Clinical Scientific Evidences On Self-Expandable Percutaneous Pulmonary Valve Implantation,Gianfranco Butera, Italy
|
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 | Flash Talk Session 5
Chair: Mara Pilati, Italy & Nora Lang, Germany
11:30 – 11:34 FT-090 Emergency Radiofrequency Atrial Septostomy In A Preterm And Small For Gestational Age Neonate With Hypoplastic Left Heart Syndrome And Prenatally Closed Foramen Ovale, Simon Schmid, Germany
11:34 – 11:38 FT-091 Percutaneous Pulmonary Valve Implantation With Venus P-Valve: A Single Center Experience, Alper Güzeltaş, Turkey
11:38 – 11:42 FT-092 Evaluating The Accuracy Of A Novel 3d Visualization Software For Preprocedural Planning Of Aortic Coarctation Stenting, Francesco Rango, Italy
11:42 – 11:46 FT-093 Mid-Term Outcomes After Pulsta Valve Implantation: Procedural Insights And Multimodality Imaging Follow-Up, Zelal Yalinkaya, Germany
11:46 – 11:50 FT-094 Restoring Flow: Mid Term Outcomes Of Transcatheter Palliation In Children With Decreased Pulmonary Blood Flow, Experience From India, Nikhil Sunil, India
11:46 – 11:50 FT-094 „Second Coronary Wire” Across Congenital Lesion Types And Complex Pulmonary Interventions: A Multi-Anatomy Technical Series And Lessons From The Cathlab Battlefield, Judyta Szeliga, Poland
11:54 – 11:58 FT-096 Covered Stent Exclusion Of Svc Stenting- Institutional Experience And An Unique Approach With Anchoring Stent, Shreesha Maiya, India
11:58 – 12:02 FT-097 Interventional Extracardiac Fontan (Iecf): Eight-Year Single-Centre Experience With A Staged, Catheter-Based Fontan Completion Strategy, Shreesha Maiya, India
12:02 – 12:06 FT-098 The Impact Of Circular Shunting As A Complication Of A Challenging Therapeutic Strategy In A Newborn With Critical Pulmonary Stenosis And Unfavorable Anatomy, Ali Jassar, Romania
12:06 – 12:10 FT-099 Balloon Versus Surgical Aortic Valvuloplasty In Neonates And Infants With Critical Aortic Stenosis: Long – Term Impact On Subsequent Interventions, Zeynep Gulben Kuk Ozalp, Australia
12:10 – 12: 14 FT-100 Procedural Time, Radiation Exposure (Dap), And Contrast Volume In Transcatheter Pulmonary Valve Implantation For Severe Pulmonary Regurgitation: A Comparison Between Self-Expanding And Balloon-Expandable Platforms, Giorgia Rocchetti, Italy
12:14 – 12: 18 FT-101 Transcatheter Embolization Of A Large Right Coronary-Cameral Fistula In A Low Weight Newborn With Heart Failure, Maurizio Brighenti, Italy
12:18 – 12:22 FT-102 Toward A National Standard: Defining Italian Diagnostic Reference Levels (Drl) In Pediatric Interventional Cardiology, Francesca De Monte, Italy
12:22 – 12:26 FT-103 Clinical Impact Of Fontan Conduit Stenting On Functional Capacity, Enrico Piccinelli, Italy
12:26 – 12:30 FT-104 The Euro-Lymph Registry: Design, Implementation, And Early Characteristics Of A European Multicenter Initiative For Lymphatic Interventions, Sanam Safi-Rasmussen, Denmark
12:30 – 12: 34 FT-105 Italian Multicenter Experience With Self-Expanding Pulmonary Valves, Francesco Prati, Italy
12:34 – 12:38 FT-106 Innovative Interventional Approach To Pediatric Thrombosis: Dubai Experience With Mechanical Thrombectomy, Ahmed Hassan, United Arab Emirates
12:38 – 12: 42 FT-107 A Multicenter Italian Experience About Trans-Catheter Patent Foramen Ovale Closure In Paediatric Age: Early Outcomes And Long-Term Follow-Up, Mario Giordano, Italy
12:42 – 12:46 FT-108 Progressive Right Ventricular Outflow Tract Obstruction Following Perimembraneous Vsd Closure With Mfo: A Rare Case Of Valve–Device Interaction, Boran Cakan, Turkey
12:46 – 12:50 FT-109 Predictors Of Residual Shunt After Patent Foramen Ovale Closure: A Single Center Study, Luca Giugno, Italy
12:50 – 12:54 FT-110 In Vitro, In Silico And Ex Vivo Characterization Of Modified Microvascular Plugs As Pulmonary Flow Restrictors: Understanding Challenges Of Device Personalisation, Nora Lang, Germany
12:54 – 12:58 FT-111 Timing and Preoperative Management of D-Transposition of The Great Arteries: Impact of Balloon Atrial Septostomy, Francesco Prati, Italy
|
| 13:00 – 14:00 |
Mentoring – Small Group Discussion
(Limited Participation – Additional Registration Required) Chairs: Ornella Milanesi, Italy
Navigating Early Career as a Female, especially in Interventional Cardiology, Alessia Callegari , Italy |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 | Flash Talk Session 6
Chair: Adam Kolesnik, Poland & Peter Fritsch, Austria
14:30 – 14:34 FT-112 Long-Term Impaired Exercise Capacity In Kawasaki Disease, Saïd Bichali, Canada
14:34 – 14:38 FT-113 Medium- To Long-Term Outcomes In A Pediatric Cohort Of L-Aaoca With Interarterial Course (L-Aaoca/Ia): Are We Changing The Landscape?, Silvana Molossi, United States
14:38 – 14:42 FT-219 Toward Physiology-Guided Neuroprotection In Infant Cardiac Surgery: A Tinybrains Multimodal Neuromonitoring Study, Marta Camprubí-Camprubí, Spain
14:42 – 14:46 FT-115 Improving Preventive Cardiology In Congenital Heart Disease: Lessons From The Qualirehab Trial, Mathieu Andrianoely, France
14:46 – 14:50 FT-116 Exercise Echocardiography In Pediatric And Congenital Heart Disease: Assessing Cardiac Reserve To Inform Clinical Decisions, Tomás Sim-Sim, Portugal
14:50 – 14:54 FT-117 Disease-Specific Reference Values For Exercise Capacity In Children With Congenital Heart Disease, Elena Gribaudo, Italy
14:54 – 14:58 FT-118 App-Based Exercise Intervention For Children And Adolescents With Congenital Heart Disease, Charlotte Schöneburg, Germany
14:58 – 15:02 FT-119 What Limits Cardiorespiratory Fitness In Adolescents With Fontan Circulation: An Integrated Haemodynamic And Pulmonary Perspective, Vibeke Klungerbo, Norway
15:02 – 15:06 FT-120 Patient Perspectives Of A Pediatric Cardiac Rehabilitation (Fitness) Program, Barbara Cifra, Canada
15:06 – 15:10 FT-121 Activity Limitations In Pediatric Fontan Circulation, Jessica Peter, Germany
15:10 – 15:14 FT-122 Ai-Enabled Digital Stethoscope For Early Detection Of Congenital Heart Disease In Children: A Prospective Study, Niharika Karandikar, India
15:14 – 15:18 FT-123 Commotio Cordis In Pediatric Athlete: Safe To Return To Play With Myocardial Scarring?, Jacob Davidson, United States
15:18 – 15:22 FT-124 Digital Diagnosis Of Cardiac Sound In Pediatric Patients [Di-Sound Study] – Preliminary Results, Vittoria Mastromarino, Italy
15:22 – 15:26 FT-125 Cardiovascular Risk Screening In Developmental Age (Riscaped Study), Silvia Alessandra Magrassi, Italy
15:26 – 15:30 FT-126 Long-Term Outcomes Of A Personalised Exercise Programme In Athletes With Inherited Arrhythmogenic Syndromes: A Single-Centre Experience, Andrea Greco, Spain
15:30 – 15:34 FT-127 Deep Learning–Derived Myocardial Strain In Children: Validation Of A Fully Automated, Open-Source Model For Left Ventricular Global Longitudinal Strain Inference, Hannah Brower-Rabinowitsch, Germany
15:34 – 15:38 FT-128 Functional Arterio–Ventricular Coupling And Its Echocardiographic Determinants In Healthy, Physically Active Adolescents, Maximilian Dettenhofer, Germany
15:38 – 15:42 FT-129 Next-Generation Sudden Cardiac Death Risk Assessment In Hypertrophic Cardiomyopathy: Integrating Cardiac Magnetic Resonance Imaging With Artificial Intelligence, Lotta Poltto, Finland
15:42 – 15:46 FT-130 Echocardiographic Assessment Of Ventricular Remodelling In Junior Athletes By Speckle Tracking Strain And Myocardial Work Indices, Massimiliano Cantinotti, Italy
15:46 – 15:50 FT-131 Pulse Wave Velocity In Children 6-18 Years After Surgical Or Interventional Repair Of Aortic Coarctation – Can We Measure Early Vascular Aging ?, Ina Michel-Behnke, Germany
15:50 – 15:54 FT-132 Effectiveness Of Ehealth-Supported Physical Activity Interventions In Children With Congenital Heart Disease: A Systematic Review, Hidde Hardon, Netherlands
15:54 – 15:58 FT-133 Ventilatory Limitation To Exercise In Patients With Fontan Circulation, Gino Degano, Italy
15:58 – 16:02 FT-134 Robustness Of The Oxygen Uptake Efficiency Slope Under Submaximal Exercise Conditions In Pediatric Cardiopulmonary Exercise Testing, Stefanie Huber, Germany
|
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 | Flash Talk Session 7
Chair: Emiliana Campagnano, Italy & Nicola Sekarski, Switzerland
16:30 – 16:34 FT-135 Formula Or Fortification Initiation Is Associated With Necrotizing Enterocolitis In Infants With Critical Congenital Heart Disease: A Multisite Study From Collaborative Research From The Pediatric Cardiac Intensive Care Society, Kristin Elgersma, United States
16:34 – 16:38 FT-136 Six-Hour Renal Resistive Index For Early Prediction Of Acute Kidney Injury After Infant Cardiac Surgery: A Prospective Cohort Study, Hamadah Mohamad Hussam, Saudi Arabia
16:38 – 16:42 FT-137 Ultrasound For Diaphragmatic Dysfunction In Postoperative Cardiac Children: A Prospective Cohort Study, Hamadah Mohamad Hussam, Saudi Arabia
16:42 – 16:46 FT-138 Human Milk And Breastfeeding Are Associated With Shorter Hospital Length Of Stay For Neonates Undergoing Cardiac Surgery: A Multisite Study From Collaborative Research From The Pediatric Cardiac Intensive Care Society, Kristin Elgersma, United States
16:46 – 16:50 FT-139 Postoperative Aeeg Monitoring Is An Essential Tool For Every Ventilated Child After Cardiac Surgery Until Extubation, Friederike Jess, Germany
16:50 – 16:54 FT-140 Oxidative Stress Biomarkers And Postoperative Mri Brain Injury In Neonates With Congenital Heart Disease, Ruth Ibáñez Llorente, Spain
16:54 – 16:58 FT-141 Artificial Intelligence In Medical Education: Perceptions And Use Among Pediatric Cardiology Fellows — A Pilot Survey Study, Sofia Grinenco, Argentina
16:58 – 17:02 FT-142 High-Sensitivity Cardiac Troponin T And Intravenous Immunoglobulin In Children With Cmr- Confirmed Or Probable Myocarditis: A Retrospective Cohort Study, Timur Mese, Turkey
17:02 – 17:06 FT-143 “Ready For Home?” Multidisciplinary And Caregiver Perspectives On Children Supported With Berlin Heart – Excor®Active (Bh-Ea): A Qualitative Study, Katharina Schmitt, Germany
17:06 – 17:10 FT-144 Outcome Determinants After Ihca And Cpr In Pediatric Cardiac Surgery Patients, Laura Glasmeyer, Germany
17:10 – 17:14 FT-145 Observational Study Of Impact Of Cardiac Cycle Efficiency In Infants Undergoing Tetralogy Repair In Terms Of Peri-Operative Outcome, Suhasinee Deokar, India
17:14 – 17:18 FT-146 Nine Years Multiplate® Testing In Infants With Shunt Dependent Lung Perfusion: Lessons Learned, Flora Staunau, Germany
17:18 – 17:22 FT-147 Practice Variation In Cardiac Care For Duchenne Muscular Dystrophy: Results Of A European Multicentre Survey, Jarosław Meyer-Szary, Poland
17:22 – 17:26 FT-148 Intraoperative Temperature Management But Not Time On Cardiopulmonary Bypass Predicts Postoperative Delirium In Children With Congenital Heart Disease, Sebastian Harms, Germany
17:26 – 17:30 FT-149 Idiopathic Left Ventricular Tachycardia: Successful Radiofrequency Catheter Ablation Under Veno-Arterial Extracorporeal Membrane Oxygenation With Additional Microaxial Left Ventricular Assist Device In A 16-Year-Old Patient, Laura Glasmeyer, Germany
17:30 – 17:34 FT-150 Levosimendan: Efficacy As A Rescue Medication In Paediatric Heart Failure And Post-Cardiac Surgery, Cyprian Umeoguaju, United Kingdom
17:34 – 17:38 FT-151 Critically Ill Neonates With Tricuspid Valve Anomalies, Jana Budáčová, Slovakia
17:38 – 17:42 FT-152 Extracorporeal Cardiopulmonary Resuscitation For In-Hospital Cardiac Arrest In Pediatric Cardiac Patients With Systemic-To-Pulmonary Artery Shunt, Kazuhiro Shoya, Japan
17:42 – 17:46 FT-153 Delivery Room And Early Postnatal Interventions With Oxygen Saturation Profiles In Newborns With Transposition Of The Great Arteries, Jesse Weeda, Netherlands
17:46 – 17:50 FT-154 The Prevention Utility Of Central Venous Pressure Management For Postoperative Delirium Following Pediatric Total Cavopulmonary Bypass, Itsumi Sato, Japan
17:50 – 17:54 FT-222 The Postoperative Course Of Troponin T And Nt-Probnp Levels In The Pediatric Population Implanted With The Heartmate 3 Device,Şeyma Şebnem Ön, Türkiye
17:54 – 17:58 FT-223 Making The Invisible Visible: Lived Experiences Of Adolescents And Young Adults Enrolled In The Transition-Chd Randomized Trial,Alyssia Venna, United States
|
| 09:00 – 10:30 | Cardiac Dysrhythmias and Electrophysiology & Sports Cardiology, Physical Activity and Prevention Abstract Session
Chair: Alice Maltret, France & Costance Weismann, Germany
09:00 – 09:07 O-050 Intracardiac Echocardiography–Guided Transseptal Puncture in the Pediatric Population: a Single-Center Experience, Mirko Topalovic, Slovenia
09:07 – 09:14 O-051 Cardiac and Muscle Health in Pediatric Super Fontans, Mavis Lui, United States
09:14 – 09:21 O-052 Ventricular Arrhythmias in Tetralogy of Fallot Patients Undergoing Pulmonary Valve Replacement: Comparison Between Proactive Slow-Conducting Anatomical Isthmus Evaluation and Ablation and Conventional Approach, Gianluca Mirizzi, Italy
09:21 – 09:28 O-053 Exercise Intensity Prescription in Pediatric Cardiology: Comparing Heart Rate Reserve and Ventilatory Threshold Methods, João Rato, Portugal
09:28 – 09:35 O-054 Surgical ICDs in Small Children: Lead Longevity, Complication Burden, and Long-Term Efficacy, Aycan Çelebi, Turkey
09:35 – 09:42 O-055 Transvenous Pacemaker and ICD Implantation in Children Under 20 kg: a Single-Center Experience With Device-Related Complications Over 25 Years, Nilay Korgal, Turkey
09:42 – 09:49 O-056 Bioelectrical Impedance Analysis Parameters as Predictors of Cardiopulmonary Exercise Capacity in Fontan Patients, Paola Koepcke, Germany
09:49 – 09:56 O-057 Clinical Outcomes of Bilateral Cardiac Sympathetic Denervation in Children With Inherited Ventricular Arrhythmias, Merve Maze Aydemir, Turkey
09:56 – 10:03 O-058 Electromechanical Interaction And Effect Of Right Ventricular Cardiac Resynchronization Therapy In Patients With Ebstein’s Anomaly Undergoing Cone Repair, Jennifer Fumanelli, Czech Republic
10:03 – 10:10 O-059 Off-Label Multi-Lead Wearable ECG Monitoring for Paediatric Syncope in Complex Congenital Heart Disease,Mindaugas Smetaninas, Lithuania
10:10 -10:17 O-060 Electromechanical Interaction in Post-Repair Tetralogy of Fallot and Similar Lesions, Michal Vrbík, Czech Republic
10:17 – 10:24 O-061 Transition From Fluoroscopic to Fluoroless Atrial Transseptal Puncture for Pediatric Catheter Ablation, Zsofia Nagy, Hungary |
| 10:30 – 11:00 | BREAK |
| 11:30 – 13:00 | Fetal Cardiology Abstract Session
Chair: Taiso Sarkola, Finland & Anna Seale, UK
11:37 – 11:44 O-063 Rigid Motion Compensation of Fetal Gross Motion and Maternal Respiration for 3D Fetal Cardiac Cine, Marjolein Piek, Sweden 11:44 – 11:51 O-064 Integrating Multimodal Imaging in Fetal Congenital Heart Disease: the Combined Role of Echocardiography and Cardiovascular MRI in a Precision Medicine Approach, Marco Masci, Canada 11:51 – 11:58 O-065 Anatomical Study of Tricuspid Atresia: Insights Into Right Ventricle Development, Julie Karila Cohen, France 11:58 – 12:05 O-066 Evaluating the Role of Fetal Speckle Tracking Echocardiography in Ventricular Disproportion?, Carla Blunt, United Kingdom 12:05 – 12:12 O-067 Impact of Fetal Pulmonary Valvuloplasty on Right and Left Ventricular Function in Fetuses With Critical Pulmonary Stenosis or Pulmonary Atresia With Intact Ventricular Septum, Martin Schoeber, Austria 12:12 – 12:19 O-068 Trends in Perinatal Outcomes of Prenatally Diagnosed Hypoplastic Left Heart Syndrome Over 20 Years, Sofie Dannesbo, Denmark 12:19 – 12:26 O-069 Increased Atrioventricular Length Ratio As A Marker Of Isomerism On Fetal Echocardiography,Zornitsa Vassileva, Bulgaria 12:26 – 12:33 O-070 Autoantibodies to the Sodium/Potassium Pump Alpha-1 Subunit AT1A1 Identify at-Risk Pregnancies That Will Develop Fetal/Congenital Heart Block: Evidence and Translational Plan, Robert Hamilton, Canada 12:33 – 12:40 O-071 Long-Term Effects of Fetal Growth Restriction on Cardiovascular Structure and Function: a Cohort Study in Growth-Discordant Identical Twins, Jip Spekman, Netherlands 12:40 – 12:47 O-072 Prenatal 3D Multiplanar Neurosonography and Artificial Intelligence-Based Assistance Scanning in Fetuses With Congenital Heart Defects, Tamara Yarygina, Russia 12:47 – 12:54 O-073 Foetal Myocardial Deformation: Insights Into Normal and Pathological Cardiac Mechanics,Irene Cattapan, Italy |
| 13:00 – 14:30 | LUNCH BREAK |
| 14:30 – 16:00 | Adult Congenital Heart Disease Abstract Session
Chair: Jolanda Sabatino, Italy & Gabriele Egidy Assenza, Italy
14:30 – 14:37 O-092 Clinical Outcomes and Right Ventricular Remodeling After Pulmonary Valve Replacement in Repaired Tetralogy of Fallot: a Meta-Analysis of Contemporary Cohort Studies, Ludovica Bossio, Italy
14:37 – 14:44 O-093 Digital Health Passport For Congenital Heart Disease Patients: Enabling Lifelong Care And Empowerment, Giovanna Campioni, Italy
14:44 – 14:51 O-094 Aortic Coarctation: Long-Term Outcomes After Repair With Vs. Without Foreign Material, Simon Schiessler, Germany
14:51 – 14:58 O-095 Long-Term Outcomes Of Heart Transplantation In Adults With Congenital Heart Disease: A Single Center Experience, Domenico Crea, Italy
14:58 – 15:05 O-096 Clinical Outcome Of Late Survivors Following The Classic Fontan Procedure, Jasmin Reyhaniye, Germany
15:05 – 15:12 O-097 Fontan-Associated Liver Disease: Clinical And Epidemiological Impact On A Large Cohort In The Uk, A Retrospective Multicenter Study, Eleonora Munaretto, Italy
15:12 – 15:19 O-098 Relationships Between Cardiopulmonary Exercise Testing, Cardiac Biomarkers, And Cmr Parameters In Young Adults With Repaired Tetralogy Of Fallot,Benedetta Leonardi, Italy
15:19 – 15:26 O-099 Factors Associated With Post-Transplantation Survival In Adults With Congenital Heart Disease: A Single Center Analysis,Selin Oncul, United Kingdom
15:26 -15:33 O-100 Diastolic Dysfunction, Atrial Mechanics And Functional Capacity In Fontan Circulation: Clinical Implications For Patients Surveillance And Heart Transplant Consideration, Ylenia Bartolacelli, Italy
15:33 – 15:40 O-101 Identification Of Risk Factors Influencing The Onset Of Fontan Failure, Victor Lengyel, Germany
15:40 – 15:47 O-102 Follow-Up Strategies and Multidisciplinary Management of Patients With Fontan Circulation: Preliminary Results of an AEPC Survey, Jolanda Sabatino, Italy
15:47 – 15:54 O-103 Expert-Recommended Integrated Cardio-Obstetric Pathway For Preconception Care In Women With Intermediate- To High-Risk Cardiovascular Conditions, Yaël Vanharen, Belgium |
| 16:00 – 16:30 | BREAK |
| 16:30 – 18:00 | Interventional Cardiology Abstract Session
Chair: Mikael Rigby, UK & Mario Carminati, Italy
16:30 – 16:37 O-104 Mid-Term Outcomes of Echocardiography-Guided Bedside Arterial Duct Closure in Premature Infants in the Neonatal Intensive Care Unit, Antonia Erb, Germany
16:37 – 16:44 O-105 Novel Bailout Technique in Melody Valve Valve-in-Valve Procedure: Ensemble Balloon Rupture and Side Cell Balloon Rescue Strategy, Anuradha Agarwal, India
16:44 – 16:51 O-106 Twelve Years of Arterial Ductal Stenting for Pulmonary Perfusion: Predictors of Technical Success and Effective Palliation to the Intended Endpoint, Katarzyna Gendera, Germany
16:51 – 16:58 O-107 Comprehensive Long-Term Follow-Up of Balloon Angioplasty in Newborns, Infants and Children, Wolfgang Radtke, United States
16:58 – 17:05 O-108 Use of Atrial Flow Regulator in Pediatric Patients With Congenital Heart Disease and Cardiomiopaties, Robert Sabiniewicz, Poland
17:05 – 17:12 O-109 Achieving a Biventricular Circulation After Pulmonary Valve Perforation in Neonates With Pulmonary Atresia and Intact Septum, Doaa Abdel Aziz, Germany
17:12 – 17:19 O-110 Outcomes of Transcatheter Pulmonary Valve-in-Valve Implantation: a Single-Centre Observational Study, Davide Ceruti, Italy
17:19 – 17:26 O-111 Outcomes of Transcatheter Patent Ductus Arteriosus Closure in Infants Weighing 2 to 6 kg, Paul Padovani, France
17:26 – 17:33 O-112 Outcomes of Patent Ductus Arteriosus Stenting in Duct-Dependent Pulmonary Circulation: a Prospective–Retrospective Study From a Tertiary Center in India, Kishore SV, India
17:33 – 17:40 O-113 Long-Term Follow Up After Transcatheter Valve Repair in Congenitally Corrected Transposition of the Great Arteries, Isabel Drexler, Germany
17:40 – 17:47 O-114 Subclinical Leaflet Thrombosis After Percutaneous Pulmonary Self-Expandable Valves: the Key Role of Valve Underexpansion, Mara Pilati, Italy
17:47 – 17:54 O-115 Transcatheter Pulmonary Valvuloplasty in Native Tetralogy of Fallot – Is It Profitable? AEPC Interventional Working Group Grant, Michal Galeczka, Poland
|
| 13:15 – 14:15 |
Session 7 – Cardiomyopathies (Totem 1)
Chair: Sophie Duignan, Ireland & Viera Illikova, Slovakia
MP-107 Longitudinal Age-Related Changes In Sinus Tachycardia Severity In Pediatric Duchenne Muscular Dystrophy Patients, Magdalena Bazgier, Poland MP-108 Cardiac Magnetic Resonance T1 Mapping And Late Gadolinium Enhancement Versus Circulating Fibrosis Biomarkers In Patients With Duchenne / Becker Muscular Dystrpophy, Barbara Burkhardt, Switzerland MP-109 The Therapeutic Effect Of Disopyramide In Children With Obstructive Hypertrophic Cardiomyopathy: A Single-Center Experience., Alicja Tomaszewska, Poland MP-110 Arrhythmogenic Right Ventricular Cardiomyopathy In Children: A Review Of The Current Literature., Francesca Cairello, Italy MP-111 Assessment Of The Ecg Markers In Children Treated For Acute Lymphoblastic Leukemia Presenting Significantly Lowered Left Ventricle Global Longitudinal Strain In Echocardiography – Preliminary Results., Julia Haponiuk-Skwarlinska, Poland MP-112 Paediatric Cardiomyopathies Incidence In Northern Ireland, A National Retrospective Cohort Study, Scott Kendall, United Kingdom MP-113 Allelic Sarcomeric Variants And Clinical Risk In Hypertrophic Cardiomyopathy, Aino Keskinen, Finland MP-114 Gm1 Gangliosidosis Presenting With Hypertrophic Cardiomyopathy In Early Infancy: A Diagnostic Pathway Through Metabolic Red Flags, Roxana Rusu, Romania MP-115 Assessing Dysfunctional Mitochondria In Congenital Cardiomyopathy, Benjamin Adebisi, Nigeria MP-116 Pediatric Cardiomyopathies: A Retrospective Clinical And Etiological Analysis With Prognostic Implications By Phenotype And Age Of Onset, Cristina Cadonati, Italy MP-117 From Cardiac Rhabdomyomas To Arrhythmias: Cardiovascular Manifestations Of Tuberous Sclerosis Complex In Children, Maria Botiș, Romania MP-118 Epidemiological Trends In Pediatric Acute Myocarditis Before, During, And After The Covid-19 Pandemic Sofia Loukopoulou, Greece MP-119 Retrospective Analysis Of General Anaesthetic Risk In Dilated Cardiomyopathy Patients, Wei Shen Cheok, United Kingdom MP-120 Mitral Valve Repair In Pediatric Dilated Cardiomyopathy With Severe Mitral Valve Regurgitation: A Promising Bridge To Heart Transplant, Maha Binfadel, Saudi Arabia MP-121 MYBPC3 Variant In Pediatric Hcm: Athlete Case Insights, Cristiana-Ioana Raita, Romania |
| 13:15 – 14:15 |
Session 8 – PAH and Heart Failure (Totem 2)
Chair: Håkan Wåhlander, Sweden & Simona Marcora, Italy
MP-122 Heart Failure In Adults With Congenital Heart Disease: Clinical Features And Prognostic Risk Factors, Lorenzo Pietropaolo, Italy MP-124 Systolic Dysfunction In Pediatric Patients With Congestive Heart Failure Secondary To Rheumatic Heart Disease In Manitoba, Canada, Oghale Ogedegbe, Canada MP-125 Deubiquitinating Enzymes Are A New Therapeutic Target For The Correction Of Ischemic-Reperfusion Myocardial Injury, Aleksandr Samorodov, Russia MP-126 When Genetics Shapes The Fate: Neonatal Fatal Cases Of Primary Pulmonary Hypertension, Alexandra Tanasescu Niculae, Spain MP-127 Single Centre Clinical Experience With Sodium-Glucose Contransporter-2 Inhibitors In Paediatric Heart Failure, Jana Zemankova, Slovakia MP-128 13 Years Of Life With An L-Vad: A Rare Case Successfully Bridged To Heart Transplantation After An Extremely Long Waiting Period, Burcugül Karasulu Beci, Turkey MP-129 Thymectomy During Iinfancy Is Associated With A Higher Burden Of Infections – A Retrospective Cohort Study Among Heart Transpalnted Children,Fatemeh Farahani, Sweden MP-130 Echocardiographic Right Ventricular Wall Tension In Extremely Preterm Infants With Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension, Melina Winkler, Austria MP-131 Vars2-Related Mitochondrial Cardiomyopathy With Severe Pulmonary Hypertension: Recovery Following Valine Therapy, Jacob Pak-lam Ho, Hong Kong MP-132 Distinct Clinical Phenotypic Presentation Of Heart Failure Across Age In Pediatric Myocarditis, Federica Ferrigno, Italy MP-133 Iron Deficiency In Paediatric Patients With Heart Failure – Preliminary Study, Filip Baszkowski, Poland MP-134 Development Of A Flow-Induced Female Pulmonary Arterial Hypertension Model As A Platform For Studying Sex-Specific Disease Mechanisms, Iris Schilthuis, Netherlands MP-135 Sacubitril/Valsartan In Paediatric Heart Failure: Early Uk Single-Centre Experience Ceit Jesmont, United Kingdom MP-137 Cardiac Magnetic Resonance–Derived Myocardial Strain In Clinically Stable Pediatric Heart Transplant Recipients, Roger Esmel-Vilomara, Spain MP-211 First Report Of Bilateral Lung Transplantation After Atrial Flow Regulator Implantation In End-Stage Pulmonary Arterial Hypertension, Brenda Mori, Italy |
| 13:15 – 14:15 |
Session 9 – Arrhythmias (Totem 3)
Chair: Andrea Bueno Gomez, Spain & Melina Winkler, Austria
MP-139 Clinical Characteristics And Outcomes Of Idiopathic Ventricular Arrhythmias In Paediatric Patients: A Retrospective Analysis, Marianna Cicenia, Italy MP-140 Clinical Outcomes Of Catheter Ablation For Atrial Arrhythmias In Adult Congenital Heart Disease Patients, Gianluca Mirizzi, Italy MP-141 Sinus Rhythm Propagation And Low-Voltage Bridge In Koch’s Triangle: How They Relate In Cryoablation Of Atrioventricular Reentry Tachycardia In Children, Francesco Flore, Italy MP-142 Pacing Therapy In Infants, Small Children And Adolecents, Mina Farag, Germany MP-143 Accuracy Of The Smart Watch Iecg For Documentation Of Supraventricular Tachycardias In Children, Sophia Klehs, Germany MP-144 Case Of Successful Thoracoscopic Right Atrial Appendage Resection As An Alternative Surgical Method Of Incessant Atrial Ectopic Tachycardia Treatment, Vitali Kadachkin, Belarus MP-146 Sedation Versus General Anesthesia: Optimizing Electrophysiological Study Outcomes In Pediatric Patients, Hakan Kucuker, Turkey MP-147 Impact Of Exercise Testing On Screening Eligibility And Vector Quality For The Subcutaneous Implantable Cardioverter-Defibrillator (S-Icd) In A Pediatric Population: A Retrospective Study, Ferran Prats-Domenech, Spain MP-148 Validation, Lead Optimization, And Diagnostic Yield Of A Sternal Single-Lead Mini-Holter In Pediatric Patients: A Prospective Study., Florian Gross, Germany MP-149 Neonatal Tachyarrhythmias In A Resource-Limited Setting: A Case Series With Echocardiographic Correlation From Ibadan, Nigeria, Cyprian Umeoguaju, United Kingdom MP-150 Genetic Forms Of Short Pr Interval – Case Series, MP-150 Genetic Forms Of Short Pr Interval – Case Series, Cecilia Lazea, MP-151 Brompton Healthy Hearts – A Physiotherapy Led Exercise Service For Children And Young People With Arrhythmia And Cardiac Devices, Jan Till, United Kingdom MP-152 Clinical Relevance Of A Cacna1c Variant In A Pediatric Athlete With Qt Prolongation: Implications For Risk Stratification, Reneta Lekova, Bulgaria MP-213 Arrhythmogenic Cardiomyopathy Beyond The Right Ventricle: A Pediatric Left Ventricular Case, Daria Lauretta, Italy |
| 13:15 – 14:15 |
Session 10 – Valvular Diseases (Totem 4)
Chair: Petru Liuba, Sweden & Elettra Pomiato, Italy
MP-154 The Effectiveness Of Warfarin Home Monitoring For Pediatric Patients With Single Ventricle Physiology And Those With Prosthetic Heart Valves: A Single Centre Retrospective Study, Manasa Ramakrishna, United Kingdom MP-156 Distinguishing Severe From Non-Severe Aortic Valve Regurgitation In Patients With Congenital Aortic Valve Disease: Identifying Discriminative Variables And Development Of A Novel Scoring System, Teresa Lerach, Germany MP-157 Long-Term Follow-Up And Natural History Of Bicuspid Aortic Valve In Children: A Single-Center Experience, Abdulkadir Babaoğlu, Turkey MP-158 Echocardiography-Guided Balloon Valvuloplasty Of Severe Neonatal Aortic Stenosis Without Fluoroscopy, Annalena Hauffe, Germany MP-159 Normative Mitral Valve Opening Surface Area In Healthy Neonates And Infants And Comparison With Age-Matched Patients With Left-To-Right Shunt Lesions, Nathalie Oeffl, Austria MP-160 Computational Modelling Of Balloon Valvuloplasty In Infant Aortic Stenosis: Linking Stress Distribution To Divergent Clinical Outcomes, Petru Liuba, Sweden MP-161 Successful Perinatal Treatment Of Circular Shunt In Fetus With Tricuspid Valve Dysplasia, Tanya Hura, Ukraine MP-162 Percutaneous Transluminal Balloon Valvoplasty And Surgical Valvotomy Comparative Analysis In Congenital Non-Critical Aortic Valve Stenosis, Ivana Cerovic, Serbia MP-163 Predictors Of Mortality In Ebstein’s Anomaly: A 34-Year Single-Center Experience, Rihab Ben Othman, Tunisia MP-164 Prediction Of Chronic Left Ventricular Dysfunction After Surgery For Severe Pediatric Aortic Regurgitation, Thomas Salaets, Belgium MP-165 Critical Aortic Stenosis, Balloon Valvulotomy And Extracorporeal Membrane Oxygenation Nathan Hahurij, Netherlands MP-166 Personalizing Warfarin Dose Adjustment In Pediatric Cardiology Using Machine Learning, Sophie Quennelle, France MP-167 Tricuspid Valve Regurgitation In Children With Congenital Corrected Transposition Of The Great Arteries: Experience Of Treatment, Olena Stohova, Ukraine MP-198 Percutaneous Tricuspid Valve-In-Valve Replacement Using A Balloon-Expandable Transcatheter Heart Valve In A High-Risk Adult With Ebstein Anomaly And Glenn Physiology: A Novel Veno-Venous Loop Approach, Anuradha Agarwal, India |
| 13:15 – 14:15 |
Session 11 – Imaging (Totem 5)
Chair: Emanuela Valsangiacomo Buchel, Switzerland & Valeria Pergola, Saudi Arabia
MP-169 Comparison Between 2d And 3d, Manual And Automated Segmentation Of Fetal Magnetic Resonance Imaging For Fetal Lung Volume Quantification, Paola Franceschi, Italy MP-170 Stress Perfusion Cardiac Magnetic Resonance Imaging Following Congenital Heart Surgery With Coronary Artery Reimplantation, ce, Ashwin Srivatsav, United Statesy MP-171 Prevalence And Determinants Of Coronary Microvascular Dysfunction In Adolescents After Arterial Switch Surgery, Andrija Pavlović, Serbia MP-172 Artificial Intelligence Shortens Acquisition Times In Magnetic Resonance For Ventricular Volume Measurements In Congenital Heart Disease Without Loss Of Quality And Accuracy, Heiko Stern, Germany MP-175 Maternal Medication Use Patterns Before And During Pregnancy And Cardiac Outcomes In Newborns, Giaan Ninh, Denmark MP-176 Multiparametric Evaluation Of Vascular Health And Myocardial Performance In Vertically Hiv-Infected Children, Adolescents And Young Adults On Cart, Mirco Cuccu, Italy MP-177 Optimizing Predictors Of Lateral And Septal Mapse For Pediatric Cardiac Assessment, Ritu Amit Chhabria, Poland MP-178 Ntracardiac Flow Vortex Analysis In Healthy Children: A Multicenter Pediatric Study, Rosalba De Sarro, Italy MP-179 Exploring Learner Experience To Inform Future Improvements In Paediatric Echocardiography Simulation Training For Novice Learners: A Qualitative, Service Evaluation Project, Daniel Geer, United Kingdom MP-180 Echocardiography Based Left Ventricular Dimension And Systolic Function Among Severely Malnourished Children When Compared With Normal Children, Demeke Mekonnen, Ethiopia |
| 13:15 – 14:15 |
Session 12 – Aortic Matters (Totem 6)
Chair: Gianfranco Butera, Italy & Matthias Sigler, Germany
MP-184 Mediastinal Hemangioma Encasing The Aortic Arch In An Infant With Coarctation Of The Aorta: A Case Report,Andriana Malska, Ukraine MP-185 The Effect Of Antenatal Screening On The Diagnosis And Management Of Aortic Arch Anomalies, Lindsey Hunter, United Kingdom MP-186 Aorta Measurments In Different Imaging Modalities – Are The Virtual Reality Software Measurments Accurate?, Michal Kapalka, Poland MP-188 Outcomes Of Surgery For Vascular Rings And Slings: A 50-Year Single-Centre Experience, Veronica Danco, Germany MP-189 Biodegradable Aortic Root Support For Reinforced Ross Procedure In Pediatric Patients, Andrea Roberto Calore, Italy MP-190 Outcomes Of Vascular Ring Resection Without Surgical Intervention On Kommerell’s Diverticulum., Steven Bibevski, United MP-191 Takayasu Arteritis Presenting As Progressive Ascending Aorta Dilation In A 12-Years-Old Girl, , Desislava Kibarova-Hristova, Bulgaria MP-192 Loeys-Dietz Syndrome: Cardiac Patterns And Outcomes, Single Centre Experience, Ahmed Elsaoudi, United Kingdom MP-193 Kawasaki Disease Shock Syndrome: Creating A Multi-Institutional Registry For A Rare Childhood Critical Illness, Hanady Al haddad, Canada MP-194 Evaluating Patients With Kawasaki Disease: Can The Systemic Immune Inflammation Index Predict Coronary Involvement?, Merve Korkut Oguz, Turkey MP-195 Cardiac Tumour Or Kawasaki Disease? A Diagnostic Conundrum, Sai Divya Sasi Kumar, United Kingdom MP-196 Transaortic Stenting Of A Reimplanted Lmca After Alcapa Repair: A Hybrid Approach For Challenging Coronary Access, , Katia Librandi, Italy MP-197 Short-Term And Long-Term Outcome Of Transcatheter Intervention For Aortic Coarctation In Pediatric Patients: A Single Centre Experience From Egypt, Shaimaa Rakha, Egypt MP-200 Pattern Of Vasculitis In The Largest Cohort Of Pediatric Aortoarteritis From A Tertiary Care Centre In India, Usha Sastry, India |
| 09:00 – 10:30 | Artificial Intelligence for Cardiovascular Load Management in Cardiac Patients and Athletes Chairs: João Rato, Portugal & Andrea Ermolao, Italy 09:00 – 09:22 Is AI the Magic Bullet to Develop Effective Preventive Strategies in Childhood?, Alberto Tozzi, Italy |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Artificial Intelligence in Paediatric and GUCH Electrophysiology – A Real GameChanger? Chairs: Nico Blom, The Netherlands & Mitchell Cohen, USA 11:00 – 11:22 Non-Invasive Digital Twin for Paediatric/Congenital EP, Henry Chubb, USA |
| 12:30 – 13:50 | CLOSING LECTURE & CLOSING CEREMONY |
| 09:00 – 10:30 | Puzzle the Expert Chairs: Sally-Ann Clur, The Netherlands & Taisto Sarkola, Finland Experts: Ulrike Herberg , Germany & Trisha Vigneswaran, UK, & Joanna Dangel, Poland & Alessia Cerutti, Italy |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Pulmonary Hypertension, Heart Failure and Transplantation Abstract Session
Chair: Milind Chaudhari, UK & Karel Koubský, Czechia
11:07 – 11:14 O-128 Immunomodulatory Treatment Strategies and Clinical Outcomes in Pediatric Parvovirus B19 Myocarditis: Insights From the Mykke Registry, Nele Rolfs, Germany 11:14 – 11:21 O-129 Pulmonary Abnormalities in Patients With Pulmonary Hypertension of Greater Than 6 Units·m² by Digital Subtraction Angiography, Kak-Chen Chan, United States 11:21 – 11:28 O-130 Totality of Evidence for Selexipag in Pediatric Pulmonary Arterial Hypertension: Integrated Analysis of Phase 2 and Phase 3 Trial Data Using Pediatric Extrapolation, Maurice Beghetti, Switzerland 11:28 – 11:35 O-131 Novel Approaches in Pediatric Pulmonary Arterial Hypertension Trials: Outcomes of Selexipag and Macitentan Pediatric Development Programs – Challenges and Successes, Mian Saeed, Switzerland 11:35 – 11:42 O-132 Optical Coherence Tomography Reveals Early Cardiac Allograft Vasculopathy Associated With Graft Dysfunction and Loss in Pediatric Heart Transplant Recipients, Lisa-Maria Rosenthal, Germany 11:42 – 11:49 O-133 Regenerative Interventions in Children, Martin Záhorec, Slovakia 11:49 – 11:56 O-134 Ovarian Cyst Rupture as a Rare Cause of Abdominal Pain and Hypotension in Female LVAD Patients: a Three-Case Series, Burcu Acar Alkan, Turkey 11:56 – 12:03 O-135 Left Atrial Hypertension and Postcapillary Pulmonary Hypertension in Infants, Children and Young Adults With Congenital and Acquired Heart Diseases: a Consensus Statement From the EPPVDN, Georg Hansmannn, Germany 12:03 – 12:10 O-136 Comparison of Hemodynamic Effects of Treprostinil and Surgical Prognosis Between Patients Combined With Pulmonary Hypertension Following Glenn and Fontan Procedures, Xiaofeng Wang, China 12:10 – 12:17 O-137 CardioMEMS Device for Monitoring Treatment Responses in Pulmonary Arterial Hypertension: Preliminary Experience in a Single Centre, Jose Manuel Puyana Rodriguez, Spain 12:17 – 12:24 O-138 Redefining Pediatric Heart Failure Therapy: Early Experience With Sacubitril/Valsartan, Rania Gargouri, Tunisia
|
| 09:00 – 10:30 | PA Banding: Revisiting An Old Technique Chairs: Caroline Ovaert, France & Massimo Padalino, Italy 09:00 -09:22 Why, How and Who Should We Band Percutaneously?, Guiti Milani, France |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Failures and Successes in the Cathlab Chairs: Thomas Krasemann, The Netherlands & Sir Shakeel Qureshi, UK 11:00 – 11:15 Transcatheter Closure of Aorto–Right Atrial Tunnel in a Neonate: When Technical Success Meets Clinical Failure, Ravi Pawar, India |
| 09:00 – 10:30 | Navigating Postoperative Challenges in Paediatric Cardiology Chairs: Segolene Bernheim , France & Elettra Pomiato, Italy 09:00 – 09:22 Complication Anticipation: Common Postoperative Issues and Their Management, Segolene Bernheim, France |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Exercise Programs in Children with CHD – What’s New? Chairs: Berardo Sarubbi, Italy & Jesse Hansen, USA 11:00 -11:22 Outcomes for Exercise Interventions in CHD: Health-related Quality of Life, Pascal Amedro, France |
| 09:00 – 10:30 | Pharmacotherapy in Pulmonary Hypertension Chairs:Hannes Sallmon, Austria & Julie Wacker, Switzerland 09:00 – 09:22 Current PH Pharmacotherapy – Effects, Side Effects and Interactions Worth Knowing About, Shahin Moledina, UK |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 |
Joint Session PCSI – AEPC
CHD-PAH Across the World: Guidelines, Late Presenters, and Real-World Decision-Making
Chairs:Jayaranganath M, India & Karin Tran-Lundmark, Sweden
11:00 – 11:22 Assessing Operability in CHD-PAH: Guideline Frameworks and Unresolved Gray Zones, Julie Wacker, Switzerland
11:22 – 11:44 Late-Presenting CHD-PAH: Physiology and Decision-Making in High-Burden Settings, Saurabh Gupta, India Complex Operability Decisions in CHD-PAH: Case-Based Panel Discussion Panellist: Jayaranganath M, India & Karin Tran-Lundmark, Sweden & Saurabh Gupta, India & Julie Wacker, Switzerland 11:44 – 11:59 Case PCSI, Saurabh Gupta, India
11:59 – 12:14 Case AEPC, Oscar van der Have, Sweden
|
| 09:00 – 10:30 | Bridging the Gap: Innovations in Paediatric-to-Adult Congenital Heart Disease Care Chairs: Pier Paolo Bassareo, Ireland & Mark Friedberg, Canada 09:00 – 09:22 Innovations in Echocardiographic Imaging Across Ages, Jolanda Sabatino, Italy |
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Flash Talk Session 8
Chair: Heynric Grotenhuis, Netherlands & Tristan Ramcharan, UK
11:00 – 11:04 FT-155 Association Between Neoaortic Arch Geometry And Adverse Outcomes Following Stage I Norwood Palliation, Vasileios Avdikos, Sweden
11:04 – 11:08 FT-156 Beyond Ejection Fraction: Ventricular Mechanics And The Functional Turning Point In Repaired Tetralogy Of Fallot Assessed By Cmr Feature Tracking, Valeria Judith Hasbani, Spain
11:08 – 11:12 FT-157 Advanced Cardiac Mri For Evaluating Myocardial Fibrosis And Hypertrophy In Patients With Aortic Coarctation, Tobias Giertzsch, Germany
11:12 – 11:16 FT-158 Longitudinal Decline Of Serial Atrial Strain With Clinical Associations In Pediatric Fontan Patients, Thipsumon Tangsiwong, Canada
11:16 – 11:20 FT-159 Role Of Outpatient Transesophageal Echocardiography In Clinical Decision-Making For Pediatric Heart Disease: A Single-Center Experience, Sweta Mohanty, India
11:20 – 11:24 FT-160 Myocardial Work Response To A Preload Challenge In The Fontan Circulation, Simone Diab, Norway
11:24 – 11:28 FT-161 Quantitative Myocardial Perfusion Imaging In Complex Congenital Heart Disease Patients – Initial Single-Center Experiences With 15o-Water Pet, Sanna Kettunen, Finland
11:28 – 11:32 FT-162 Right Heart Remodeling And Rhythm Dynamics After Asd Closure: A Comparison Of Surgical And Transcatheter Approaches, Nida Gülderen Kalay Şentürk, Turkey
11:32 – 11:36 FT-163 The Use Of Ecg-Gated Computed Tomography In Pediatric Population – Comparison With Non-Gated Studies And Cancer Risk In Heart Transplantation Surveillance, Netta Ihanainen, Finland
11:36 – 11:40 FT-164 3d Echocardiographic Evaluation Of Tricuspid Annulus Morphology In Patients With Pulmonary Atresia Or Severe Pulmonary Valve Stenosis With Intact Ventricular Septum, Mika Saito, Japan
11:40 – 11:44 FT-165 Optimizing Hemodynamic Assessment By Integrating Cardiovascular Magnetic Resonance Flow Quantification With Catheterization Measurements, Marlene Furtmüller, Germany
Association Of Non-Invasive Right Ventricular To Pulmonary Artery Coupling With Invasive Hemodynamics And Functional Class In Children With Pulmonary Hypertension, Lucía Deiros-Bronte, Spain
11:44 – 11:48 FT-167 The Use Of The Technical Performance Score In The Norwood Procedure For Predicting Adverse Outcomes, Lia Davies, United Kingdom
11:48 – 11:52 FT-168 Longitudinal Echocardiographic Assessment In Patients With Primary Hyperoxaluria Type 1, Katharina Linden, Germany
11:52 – 11:56 FT-169 Left Atrial Strain Pattern In Different Phenotypes Of Pediatric Cardiomyopathy, Iolanda Muntean, Romania
11:56 -12:00 FT-170 Non-Invasive Assessment Of Vortex Patterns In Pediatric Ventricular Septal Defect Using Hyperdoppler Technology, Giulia Pelaia, Italy
12:00 – 12:04 FT-171 The Role Of Stress Echocardiography In The Follow-Up Of Repaired Congenital Heart Disease With Right Ventricle Outflow Tract Obstruction, Gabriella Gaudieri, Italy
12:04 – 12:08 FT-172 4d-Flow Cmr Reveals Reduced Pulmonary Flow Adaptability In Paediatric Fontan Circulation Compared With Healthy Controls, Frida Dangardt, Sweden
12:08 – 12:12 FT-173 Echocardiographic Assessment For Coronary Aneurysms In Kawasaki Disease: Results From A Systematic And Standardized Echocardiographic Method Of Diagnosis In Pediatrics, Francesco Bianco, Italy
12:12 – 12:16 FT-174 Correlation Of Echocardiographic Findings And Cmr Derived Ejection Fraction (Cmr-Ef) In Functionally Univentricular Hearts (Fuvh), Florian Loeffelbein, Germany
12:16 – 12:20 FT-175 Right Ventricular Dysfunction In Repaired Tetralogy Of Fallot: New Imaging Insights From Systolic Stretch Patterns, Emmanuelle Fournier, Canada
12:20 – 12:24 FT-176 Impact Of Overweight And Obesity On Blood Pressure And Cardiac Remodelling In Pediatric And Young Adult Patients With Congenital Heart Disease, Benedetta Leonardi, Italy
12:24 – 12:28 FT-177 Postoperative Longitudinal Myocardial Mechanics In Children With Aortic Regurgitation: Insights From Gls And Glsr Indexed To Wall Stress, Ana Alexandra Oliveira, Belgium
|
| 09:00 – 10:30 | Flash Talk Session 9
Chair: Thomas Möller, Norway & Monica De Gaspari, Italy
09:00 – 09:04 FT-178 Identification of Novel Biomarkers via Metabolomic Profiling in Diagnosis and Monitoring of Pediatric Patients With Myocarditis, Seçil Sayın, Turkey
09:04 – 09:08 FT-179 Apolipoprotein B Level Elevation and Glutathionylated Proteins as New Biomarkers for Cardiac Hypertrophy in Children, Sara Di Marzio, Italy
09:08 – 09:12 FT-180 Clinical Characteristics and Predictors of Major Adverse Cardiac Events in Pediatric Hypertrophic Cardiomyopathy: a Multicenter Registry Study, Keiichi Hirono, Japan
09:12 – 09:16 FT-181 Morpho-Functional Characterization of Gene-Elusive Versus Gene-Positive Hypertrophic Cardiomyopathy in Children: a CMR-Based Study, Francesca Bonanni, United Kingdom
09:16 – 09:22 FT-182 Clinical Application of Blood Biomarkers and Heart Failure Scoring Systems in Children With Left to Right Shunts, Claire McGinn, United Kingdom
09:22 – 09:26 FT-183 Long-Term Outcomes of Pediatric Dilated Cardiomyopathy After Berlin Heart EXCOR® Explantation With Recovery of Cardiac Function, Yuka Hayashida, Japan
09:26 – 09:30 FT-184 Machine Learning-Based Mortality Prediction for Pediatric Fulminant Myocarditis Using Cytokine Profiles, Saori Sugawara, Japan
09:30 – 09:34 FT-185 Cardiac Troponins in Urine, Matija Bakoš, Croatia
09:34 – 09:38 FT-186 Natural Wave Velocity as a Marker of Fibrosis in a Reversible Right Ventricular Pressure Overload Model, Maelys Venet, France
09:38 – 09:42 FT-187 Cardiopulmonary Exercise Testing in Paediatric Hypertrophic Cardiomyopathy: Functional Profiles and Prognostic Value, Gian Luca Ragazzoni, Italy
09:42 – 09:46 FT-188 Non-Invasive Markers of Graft Injury in a Cohort of Paediatric and ACHD Patients After Heart Transplant: an Interim Analysis, Simone Bonetti, Italy
09:46 – 09:50 FT-189 Myocardial Recovery After Mitral Valve Surgery in Children With Marfan Syndrome: a Multicentre European Study, Simon D’hulst, Belgium
09:50 – 09:54 FT-190 Early Right Ventricular Remodeling in an Experimental Model of Pulmonary Regurgitation, Nathalie Müller, Germany
09:54 – 09:58 FT-191 Using Wearable Technology to Monitor Exercise Capacity in Childhood Hypertrophic Cardiomyopathy, Kayla Hopkins, United Kingdom
09:58 – 10:02 FT-192 Longitudinal Evaluation of Lymphatic Abnormalities in Noonan Syndrome and Mosaic RASopathies Using Sequential Dynamic Contrast-Enhanced Magnetic Resonance Lymphangiography, Inger Norlyk Sheyanth, Denmark
10:02 – 10:06 FT-193 Exploring Clinical Features Indicating High Risk for Adverse Outcome in Hypertrophic Cardiomyopathy Associated With Noonan Syndrome and Other RASopathies, Ingegerd Östman-Smith, Sweden
10:06 – 10:10 FT-194 Clinical Features and Outcomes of Pediatric Restrictive Cardiomyopathy, Hidekazu Ishida, Japan
10:10 – 10:14 FT-195 MYH6 in Congenital Heart Defects: a Genotype-Phenotype Characterization in a French Cohort, Elise Daire, France
10:14 – 10:18 FT-196 Genetic Analysis and Clinical Outcomes of Noncompaction Cardiomyopathy in Fetuses and Children, Balaganesh Karmegaraj, India
10:18 – 10:22 FT-197 A Multi-Gene Regenerative Strategy to Boost Cardiomyocyte Proliferation and Angiogenesis Following Myocardial Injury, Agustina Scharn, Italy
10:22 – 10:26 FT-225 Lipidomics Landscape In Patients With Univentricular Heart Post-Fontan, Lamia Ait Ali, Italy
10:26 – 10:30 FT-226 Survival And Comorbidities In Down Syndrome: Insights From A Large Cohort Analysis (1990-2023), Courtney Potts, United Kingdom
|
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Flash Talk Session 10
Chair: Jolanda Sabatino, Italy & Antoine Abdelmassieh, Egypt
11:00 – 11:04 FT-198 Elevated Fecal Alpha1-Antitrypsin Concentration in Asymptomatic Fontan Patients Is a Risk Factor for the Development of Protein-Losing Enteropathy: a Report From the Fontan Care Network, Kim Dam, Netherlands
11:04 – 11:08 FT-199 Serum Catecholamine Levels as Biomarkers in Children With Pulmonary Arterial Hypertension, Faye Smits, Netherlands
11:08 – 11:12 FT-200 Systolic and Diastolic Right Ventricular Myocardial Stiffness Based on Shear Wave Elastography in Pediatric Pulmonary Hypertension, Maelys Venet, France
11:12 – 11:16 FT-201 Novel Data-Driven Phenotypic Clustering Approach for Predicting Prognosis in Paediatric Pulmonary Arterial Hypertension, Chantal Lokhorst, Netherlands
11:16 – 11:20 FT-202 Atrial Strain as a Marker of Diastolic Dysfunction in Children With Fontan Circulation, Carmen Corina Şuteu, Romania
11:20 – 11:24 FT-203 Mechanical Signatures Of Post-Myectomy Lbbb In Pediatric Hypertrophic Cardiomyopathy, Merve Maze Aydemir, Türkiye
11:24 – 11:28 FT-204 Twenty-Year Structured Hepatic Surveillance in Fontan Patients: Evidence of Progressive Remodeling in a Contemporary Cohort, Ana Raquel Marques, Portugal
11:28 – 11:32 FT-205 Comparative Outcomes of Stage 1 Interventional Extracardiac Fontan Versus Conventional Bidirectional Glenn: Real-World Experience From a South Asian Tertiary Centre, Varun Govindarajan, India
11:32 – 11:36 FT-206 Population Pharmacokinetic Modeling of Tadalafil in Pediatric Pulmonary Hypertension to Apply to Pharmacodynamic Analyses, Takuya Wakamiya, Japan
11:36 – 11:40 FT-207 Quantitative Profiling of the Pulmonary Arterial Bed Using CTA-Thorax Shows Distinct Volumetric Patterns in Pulmonary Arterial Hypertension of Childhood, Rosaria Ferreira, Netherlands
11:40 – 11:44 FT-208 Structural Capillary Rarefaction and Venous Abnormalities in Fontan and Post Tetralogy Repair Adults: a Pilot Study, Rajendra Raghuraman, United Kingdom
11:44 – 11:48 FT-209 Structural Equation Modelling and Multimodal Prognostic Scores in Repaired Tetralogy of Fallot, Lorenzo Ridolfi, France
11:48 – 11:52 FT-210 Chest Pain and Troponin Rise in a Young Adult With Repaired Tetralogy of Fallot: Not Always Myocarditis, Giulia Guglielmi, Italy
11:52 – 11:56 FT-211 Right Ventricular Adaptation to Pressure Versus Volume Load After Tetralogy of Fallot Repair – Integrating Clinical Data With Multimodality Experimental Models, Gilles Mets, Belgium
11:56 – 12:02 FT-212 Iron Deficiency in Adults With Complex and/or Cyanotic Congenital Heart Disease: Which Diagnostic Criteria Identify Clinically Relevant Disease?, Fabian von Scheidt, Germany
12:02 – 12:06 FT-213 Clinical Burden and Treatment Patterns in Adults With Systemic Right Ventricle: Insights From the Pathfinder-CHD Registry, Fabian von Scheidt, Germany
12:06 – 12:10 FT-214 AI Assisted Mortality Risk Stratification in Eisenmenger Syndrome, Estibaliz Valdeolmillos, France
12:10 – 12:14 FT-215 Restrictive Lung Function Is Common in Children With Fontan Palliation and Functionally Highly Relevant With Disproportionate Exercise Limitation, Alina Ofenheimer, Switzerland
12:14 – 12:18 FT-216 Coagulation Phenotype for Risk Stratification in Single-Ventricle Infants: a Multicenter Longitudinal Analysis, Alessia Callegari, Switzerland
12:18 – 12:22 FT-217 Portal Vein 4D-Flow Dynamic Evaluation in Fontan Circulation, Akio Inage, Japan
12:22 – 12:26 FT-218 Linking Decreased Wall Shear Stress in Pulmonary Arteries and Serum Proteomics: Mechanotransduction in the Fontan Circulation, David Renaud, Poland
12:26 – 12:30 FT-228 Age Normalised Sinus Tachycardia On 24-Hour Holter Ecg Effect On Left Ventricular Ejection Fraction In Duchenne Muscular Dystrophy Children,Jarosław Meyer-Szary, Poland
|
| 09:00 – 10:30 | Paediatric Cardiovascular Intensive Care & General Cardiology Abstract Session
Chair: Andrea Greco, Spain & Benedetta Leonardi, Italy
09:00 – 09:07 O-116 Phenotype in Marfan Syndrome With High Cardiovascular Risk. Who Needs Surgery During Childhood?, Veronika Stark, Germany
09:07 – 09:14 O-117 Use and Outcome of Anticoagulant Therapy in Children With Congenital Heart Disease: Insights From a Nationwide Population Based Study, Jana Logoteta, Switzerland
09:14 – 09:21 O-118 Right Aortic Arch From Fetal to Long-Term Follow-Up: Diagnosis, Management and Outcomes in More Than 30 Years, Cosimo Marco Campanale, Italy
09:21 – 09:28 O-119 VSD-Prove: Interim Results of Surgical Closure of Large VSD With Severe PAH in Children Older Than 2 Years, Saurabh Gupta, India
09:28 – 09:35 O-120 Mapping Care Pathways in the Last Year of Life in Congenital or Acquired Complex Chronic Heart Conditions: a Pediatric Observational Study, Ashley Ridley, France
09:35 – 09:42 O-121 Comprehensive Assessment of the Risk of Developing Coronary Artery Aneurysm in Kawasaki Disease: Kawacor Score Study, Stasa Krasic, Serbia
09:42 – 09:48 O-122 Metabolic Bone Disease in Fontan Patients: a Systematic Review and Meta-Analysis, Kerri Munn-Bookless, United Kingdom
09:48 – 09:54 O-123 Early Echocardiographic Risk Stratification for Aortic Valve Prolapse and Regurgitation in Infants With Isolated Ventricular Septal Defect, Nujin Uluğ Murt, Turkey
09:54 – 10:01 O-124 Relationship Between Baseline NT-proBNP, Phenotype and Outcomes in Children With Hypertrophic Cardiomyopathy, Giuseppe Izzo, Italy
10:01 – 10:08 O-125 Cardiac and Autonomic Characteristics of Children With Duchenne and Becker Muscular Dystrophy, Betül Seda Guzelhan, Turkey
10:08 – 10:15 O-126 The Importance of Vitamin D Monitoring in the Fontan Population, Abdulla Tarmahomed, United Kingdom
10:15 -10:22 O-153 The Challenge of Late Repair of Tetralogy of Fallot in Children, Beatriz Picazo-Angelin, Spain
|
| 10:30 – 11:00 | BREAK |
| 11:00 – 12:30 | Cardiovascular Morphology & Education / Training & General Cardiology Abstract Session
Chair: Annalisa Angelini, Italy & Alvise Guariento, Italy
11:00 – 11:07 O-139 Factors and Outcomes Associated With Time From Fever Onset to Initial Treatment With Intravenous Immune Globulin for Patients With Acute Kawasaki Disease, Brian McCrindle, Canada
11:07 – 11:14 O-140 Cardiac Structure and Function in Moderate-to-Late Preterm Newborns, Eleonora M. Gjerløff, Denmark
11:14 – 11:21 O-141 PDA and ASD Closure in Preterm Infants: Safety and Early Outcomes, Petru Liuba, Sweden
11:21 – 11:28 O-142 Real World Utility of a Mobile Application Based Echocardiographic Triage Tool for Early Detection and Referral of Neonates With Critical Congenital Heart Disease, Navaneetha Sasikumar, Canada
11:28 – 11:35 O-143 Research Opportunities Across Medical Training Among Pediatric Cardiology Fellows and Specialists: Interim Results of a Nationwide Survey From Türkiye, Boran Çakan, Turkey
11:35 – 11:42 O-144 From Netflix to the Bedside: Transforming Paediatric Cardiovascular Critical Care Training for Today’s Trainees, David Ferri Rufete, Spain
11:42 – 11:49 O-145 Morbidity and Predictors of Serious Events in Children and Adolescents With Repaired Tetralogy of Fallot: a Swedish Nationwide Study, Misha Bhat, Sweden
11:49 – 11:56 O-146 Entrustable Professional Activities as an Assessment Tool for a Global Pediatric Cardiology Curriculum: Results From an International Survey – an Empowering Hearts Globally Initiative, Shubhika Srivastava, United States
11:56 – 12:03 O-147 Virtual Reality as an Educational Aid for Pediatric Cardiology Trainees in Diagnosing Complex CHD Lesions, Leonard Grossmann, Canada
12:03 – 12:10 O-148 Aberrant Subclavian Artery in Interrupted Aortic Arch With Severe Left Ventricular Outflow Tract Obstruction: Random Occurrence or Purposeful Adaptation During Embryonic Development?, Takeshi Tsuda, United States
12:10 – 12:17 O-149 Morphological Analysis of 109 Cases of Double-Outlet Ventricles Using Immersive 3D Virtual Reality and Digital Dissection, Sakthi Saravanan, India
12:17 – 12:24 O-150 The Morphological Spectrum of Fatal TAPVD: a 25-Year Single Centre Experience, Saad Ahmad Malik, United Kingdom
12:24 – 12:31 O-151 Empowerment Of Adolescents And Young Adults With Congenital Heart Disease, Giuseppina Sequi, Italy
|